15 - 17 January 2016 Bangkok, Thailand
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health Strengthening collaboration and capacity in Asia and the Pacific
http://www.ashm.org.au/international-programs/international/regional-network
Contact Regional Network Locked Mail Bag 5057, Darlinghurst NSW 1300 t +61 2 8204 0719 | f +61 28204 0782 | e regionalnetwork@ashm.org.au ashm Supporting the HIV, Viral Hepatitis and Sexual Health Workforce
Dear colleagues and friends, Welcome to the 1st Assembly of the Regional Network in HIV, Viral Hepatitis and Sexual Health Medicine. This meeting represents a long held goal of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) to facilitate links between clinical societies in the Asia & Pacific regions that through their collective knowledge and experience might contribute meaningfully to the response to blood borne viruses (BBVs) and sexually transmitted infections (STIs). An earlier manifestation occurred at the 2014 International AIDS Conference in Melbourne at a Leadership and Mentoring Program (developed collaboratively by ASHM and a number of societies from the region with whom we were actively working in capacity development at the time). The success of this venture led us to wonder whether this initial project could be expanded into something broader and bolder aimed at longer term, sustainable collaborative projects with cross fertilisation between the diversity of high-, middle- and low income countries of the AP region. ASHM took on this task. This Assembly is the result. To make the vision a reality we have contacted 90 organisations and to date 42 have signed up to the network with 56 people registered for this inaugural meeting. It is important to state clearly from the outset that ASHM, while delighted to be able to facilitate this meeting does not have any preconceived notion of how this venture may develop and operate. We hope that this first Assembly will provide an opportunity for the various organisations represented to discuss, debate and define the mission, aims and operations of the network. To that end we will set up a secretariat at the ASHM offices that will promote communications and develop projects in liaison with network members after the completion of the Assembly. ASHM has played an important role in the Australasian response to BBVs and STIs. This has been characterised by collaboration between the health care sector and affected communities from the outset. ASHM has drawn on the strength and dedication of its membership and staff to promote best practice in the diagnosis, treatment and prevention of blood borne viruses and sexually transmitted diseases; for instance, it led the complicated process of having the CD4+ count threshold for initiation of antiretroviral therapy removed the year prior to the release of the START study results. No other organisation in the country had the knowledge, skill set and human resources required to effect this change. In the area of hepatitis C, ASHM has consistently collaborated with health care and community groups in promoting unrestricted access to the new directly acting antivirals. In response the Australian government has recently announced unrestricted access to these agents in the first national attempt anywhere in the world to eradicate HCV. ASHM supports and sustains a formidable array of activities in its response to the key infections of interest. It produces online guidelines in living document form that keep up to date with the readily shifting evidence on best-practice management of various infections; develops policy and responds to the policy developments of other societies and government; supports training, education, mentoring and leadership; provides representatives to give ASHM input into the deliberations of numerous committees; organises conferences and meetings; provides scholarships; promotes research and evidence-based responses to health care problems and much more besides.
2
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
ASHM has been a key organisation in coordinating Australia’s response to HIV, viral hepatitis and sexually transmitted diseases and will continue to be into the future. We wish to partner with regional societies to exchange knowledge and share experiences and learnings to propel future progress in addressing BBVs and STIs across the region. Internationally however, this past year has been difficult; the Australian Government has changed its focus on health to economic development predominantly, and has cut its aid budget by 20% over the next 5 years. Policy changes like these in combination with sluggish global economic growth have meant that commitments to funds supporting work in major infectious diseases are becoming harder to replenish. Contributions to the Global Fund have flat-lined since the Global Financial Crisis. Increasingly countries are being asked to contribute more to their HIV responses as external aid becomes harder to sustain, let alone augment. Important background to these difficulties is that this month we have moved from the era of the UN Millennium Development Goals (MDGs; 2001-2015) into the era of the UN Sustained Development Goals (SDGs; 2016-2030). While actions to combat HIV, TB and malaria were highlighted and heavily promoted in Goal 6 of the 8 MDGs, Health itself forms only 1 of the 17 SDGs and the action of ‘eradication of HIV’ is only part of one of 169 aspirational targets to be reached by 2030. To make up for the inevitable shortfall in prominence, funding and support for addressing blood borne viruses and STIs that will accompany this transition we must be nimble and innovative in how we continue to address BBV, STI and other infectious disease epidemics around the world and in our region in particular. I believe that this Asia Pacific regional network initiative will respond to the SDG era by harnessing the invaluable collective experience, knowledge and reach of the numerous regional professional societies. Together we can partner with like-minded organizations to continue to effectively address BBVs and STIs across the region into the future. Finally, let me say that it gives me particular pleasure to be co-hosting this inaugural meeting in Bangkok with Professor Praphan Phanuphak of the Thai Red Cross AIDS Research Centre and HIV-NAT. HIV-NAT is an outstanding example of what can be achieved when those with common goals collaborate to achieve a success outcome. If this new network manages even half the success of HIV-NAT we will have done well. I look forward to meeting old colleagues and friends and making new ones over the weekend. A/Prof Mark Boyd President Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) January 2016
Society representatives from Asia and the Pacific meet in Melbourne at the AIDS 2014 Conference.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au3
3
Table of Contents
Emergency Contacts ............................................................................................................................. 4 General Information ............................................................................................................................. 5 Speakers ............................................................................................................................................... 13 Program ............................................................................................................................................... 14 Session information ............................................................................................................................. 18 Summary of Members key activities ................................................................................................... 21 Country & Members profiles ............................................................................................................... 30 Member & contacts list ....................................................................................................................... 83
Thailand Emergency Contacts Information: Note: to reach an English-speaking operator call the Tourist Police or in the case of an accident, an ambulance service from one of the many international hospitals in Thailand.
Emergency Services Tourist Police
1155
Police (General Emergency Call)
191
Ambulance and Rescue
1554
Fire
199
National Disaster Warning Centre
1860
Crime
1195
Medical Emergency Call
1669
Private Air Ambulance (Siam Air Care)
4
Telephone
02 586 7654
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
General information
Co-host – Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) ASHM is a peak organisation of health professionals in Australia and New Zealand who work in HIV, viral hepatitis and sexually transmissible infections. ASHM draws on its experience and expertise to support the health workforce and to contribute to the sector, domestically and internationally. ASHM is a professional, not-for-profit, member-based organisation. It supports its members, sector partners and collaborators to generate knowledge and action in clinical management and research, education, policy and advocacy in Australasia and internationally. It is committed to quality improvement, and its products and services are sought after by governments, members, health care workers and affected people. ASHM's dedicated membership, high-calibre staff and commitment to partnership assure its effectiveness in achieving its mission. ASHM works collaboratively and in partnership to prevent HIV, viral hepatitis and STIs, and to preserve and protect the health of those living with these infections. It aims to function as a cohesive and inclusive group of professionals, advancing its vision in a skilled, informed, compassionate and appropriate way.
Co-host - Faculty of Medicine Chulalongkorn University
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
5
General Information
Website: http://www.ashm.org.au/international-programs/international | Email: International.mailbox@ashm.org.au ASHM International supports capacity-building, leadership and mentoring, professional societies, and educational initiatives across the Asia-Pacific. The International Program extends ASHM’s mission of supporting the HIV, viral hepatitis and sexual health workforce. The Program generally aligns with those countries identified as priorities by the Australian Department of Foreign Affairs and Trade in Asia and the Pacific in terms of national and regional HIV responses. It involves a range of educational activities and programs in Asia and the Pacific. ASHM partners with other professional societies that support the capacity development of the HIV, sexually transmissible infections (STI) and/or viral hepatitis related health workforce.The aim is to enhance the clinical capacity of these countries by helping to build supporting networks as well as professional development. The International Program also includes ASHM’s Regional Partnership Program. The Regional Partnership Program aims to support sustainable professional capacity development in HIV and the related diseases sector. This is achieved through the provision of mentoring and the enhancement of leadership skills.
Website: http://www.ashm.org.au/conferences | Email: conferenceinfo@ashm.org.au ASHM Conference, Sponsorship and Events Division is an independent division within the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), specifically established to support the medical, health and scientific sectors via the delivery of professional, memorable, and successful conferences and events. Since 2002, the team has provided a diverse range of customised conference and event management services to organisations and government departments in the areas of research, science, medicine, health policy and education
Assembly Venues Friday 15th Jan 2016 Ballroom and Reception Hall A Queen Sirikit National Convention Centre (QSNCC) 60 New Rachadapisek Klongtoey Bangkok 10110, Thailand Phone: +66 2 229 3000 Public transit access: Queen Sirikit National Convention Center MRT Station
6
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
General Information
Saturday 16th & 17th Jan 2016 Meeting Room – 25th Floor
Accommodation
Dormitory Faculty Development
Holiday Inn Sathorn
King Chulalongkorn Memorial hospital
Location: 51 Soi Pipat, Silom, Bangrak,
1873 Rama IV Road, Bangkok, Pathumwan 10330, Thailand
Bangkok 10500, Thailand
Phone: +66 2 256 4000
Phone: +66 2 660 2800
Transport and Travel Travelling from Suvarnabhumi Airport: Delegates are advised to take a taxi to their accommodation; delegates should take a metered taxi which should not cost more than 400 TBH and an addition 50 TBH airport surcharge. Delegates may be able to share taxis if leaving directly from the venue on Sunday 17 January.
Travelling from Don Mueang International Airport: Delegates are advised to take a taxi to their accommodation; delegates should take a metered taxi, this should cost approximately 400 TBH.
Getting to Queen Sirikit National Convention Centre Both venues for this event are located in central or downtown area. Taxis and public transport (sky rail, MRT, buses and taxis) can be easily accessed from both venues to accommodation at Holiday Inn Sathorn. QSNCC is approximately 5.3 km away from Holiday Inn Sathorn. QSNCC is conveniently accessible by BTS Skytrain, MRT subway, taxi, buses and car. Nearest Skytrain station to Holiday Inn Sathorn is Chong Nonsi Station. There are few options. 1.
Change from sky train at S2- Sala Daeng station to connecting MRT train at Silom station. Get off at Queen Sirikit National Convention Centre station and take exit 3 for QSNCC or alternatively walk to Silom MRT station and catch train to QSNCC centre.
2.
Take the BTS Skytrain to Asok interchange station, where you catch the subway to MRT Queen Sirikit National Convention Center station. Follow exit no. 3 to the QSNCC. This is long route and requires train interchange at Siam station.
3.
QSNCC is also accessible through buses from Sathon Tai Road and Silom road.
Passes are available for purchase starting at minimum 100TBH. This includes 70TBH travel money and 30TBH deposit. You can also buy one-day pass or single trip pass from ticket office or ticket machines.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
7
General Information
Getting to King Chulalongkorn Memorial Hospital and Crown Plaza, Lumpini Park King Chulalongkorn Memorial hospital is approximately 1.3 km away and Crown Plaza Lumpini Park is approximately 1 km away from Holiday Inn Sathorn. Both this venues are at walking distance from Holiday Inn Sathorn. If you are catching Skytrain from Holiday Inn Sathorn, board it from Chong Nonsi Station and get off at Saladaeng Station or Rajdamri Station. To get to Crown Plaza, Lumpini Park – get off at Saladaeng Station.
Crown Plaza Lumphini Holiday Inn Express Bangkok Station
8
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
General Information
Queen Sirikit National Convention Centre Ballroom and Reception Hall A Zone A.
VENUE
Ballroom & Reception Hall A
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
9
General Information
Registration Desk All enquiries should be directed to the registration desk located outside the presentation room at the Convention Centre and outside the meeting room located on 25th Floor on Saturday and Sunday at King Chulalongkorn Memorial hospital. Friday 15th January
12.00 pm - 5.30pm
Saturday 16th January
7.30 am - 5.00 pm
Sunday 17th January
8.30 am - 12.00 pm
Preparation for Presentation Please provide Assembly staff with your presentation on a USB 30 minutes prior to your presentation
Resource Table A resource table will be available for participants to display information about their organisation and their work in field of HIV, viral hepatitis and STIs. Delegates are encouraged to share information with other participants of the Assembly.
Wireless Internet Wireless internet will be available on site. Please ask at Registration desk for further details.
Catering Morning teas, afternoon teas and lunches will be held in a separate room at the venue on same floor on Saturday and Sunday.
Emergency and Evacuation Procedures In the event of an emergency, such as a fire, the venue staff will direct delegates accordingly or follow the directions from Assembly staff.
Smoking This Assembly, Conference Centre and Hospital have non-smoking policies.
Mobile Phones/Beepers As a courtesy to all delegates and speakers, please switch off, or set to silent, your mobile phones and beepers during all sessions.
10
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
General Information
Name Badges Name badges will be provided to all delegates at the registration desk on Friday. For security purposes, all attendees must wear their name badge at all times while in the Assembly venue. If you misplace your name badge, please advise staff at the registration desk.
Evaluation Surveys will be provided to delegates during the Assembly. These will be collected at the registration desk and a summary included in to the Assembly proceedings and report.
Liability/Insurance In the event of industrial, social or political disruptions or natural disasters the Conference secretariat cannot accept responsibility for any financial or other losses incurred by delegates. Nor can the Secretariat take responsibility for injury or damage to property or persons occurring during the Conference or associated activities. Insurance is the responsibility of the individual delegate.
Photography A photographer will be onsite throughout the Assembly. The images may be used for post-meeting reports, case studies, marketing collateral and supplied to the industry media if requested. If you do not wish for your photo to be taken, please advise the photographer or the registration desk and move out of the camera range.
Conference Environment Policy ASHM implements a waste-reduction policy that addresses: Reduce, Reuse, Recycle. This is done before, during and after each Conference. Our waste-reduction policy aims to implement the following strategies: •
reduce the number of printed materials by using electronic communication means wherever possible, including the website, email, online registration and abstract submission.
•
monitor final delegate numbers for an accurate forecast of catering requirements in order to avoid waste.
•
research and prioritise purchasing items and equipment that support the use of recycled materials or can be recycled after use.
The conference satchel is made from recycled plastic bottles. It is a strong reusable backpack which can be folded into a handy purse/pocket size. As part of our cost reduction strategy we are repurposing bags left over from the recent Australasian HIV and AIDS and International Sexual Health and HIV Conferences held in Brisbane in 2015.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
11
Associated events
Networking Event and Reception Date:
Friday 15th January 2016
Time:
5.30 pm – 7.00 pm
Location:
Meeting room 3, Queen Sirikit National Convention Centre (QSNCC)
60 New Rachadapisek Klongtoey Bangkok 10110, Thailand
Phone:
+66 2 229 3000
Regional Network Dinner
12
Date:
Saturday 16th January 2016
Time:
6.30 pm
Location:
Crown Plaza Lumpini, Bangkok, Lumpini Park
952 Rama IV Road, Bangkok 10500 Thailand
Phone:
+66 2 632 9000
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Speakers
Dr Alec Akeroma
Pacific Society for Reproductive Health
Dr Sophia Archuleta
National University of Singapore, HIV Programme
A/Prof Mark Boyd
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Dr Roy Chan
Action for AIDS, Singapore
Dr Arvin Chaudhary
Oceania Society for Sexual Health and HIV Medicine
A/Prof Levinia Crooks
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Dr Phillip Cunningham
St Vincents Hospital Sydney Limited
Prof Samsuridjal Djauzi
University of Indonesia; Indonesian Association of Physicians in AIDS Care
Mr David Fowler
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Dr Somesh Gupta
International Union of Sexually Transmitted Infections (IUSTI) - Asia Pacific Region
Prof Adeeba Kamarulzaman
University of Malaya
Dr Steve Kerr
HIV Netherlands Australia Thailand Research Collaboration
Dr Nor Shahidah Khairullah
Malaysian Liver Foundation
Dr Nguyen Van Kinh
Vietnam Clinical HIV/AIDS Society
Mr Steve Kraus
Regional Support Team for Asia and the Pacific, UNAIDS
Dr Nagalingeswaran Kumarasamy
YRGCARE
Dr David Lewis
Australasian Sexual Health Alliance
Prof Sharon Lewin
Doherty Institute
Dr Ying-Ru Jacqueline Lo
World Health Organisation, Western Pacific Regional Office
Dr Maria Isabel E. Melgar
AIDS Society of the Philippines
Dr John Millan
Papua New Guinea Sexual Health Society (PNG SHS)/Collaboration for Health in Papua New Guinea (CHPNG)
Prof Rosmawati Mohamed
University Malaya Medical Centre
Ms Shanti Noriega
RTI International
Dr Razia Pendse
World Health Organisation, South East Asia Regional Office
Prof Praphan Phanuphak
Thai Red Cross AIDS Research Centre
Dr Kiat Ruxrungtham
HIV Netherlands Australia Thailand Research Collaboration, Thai Red Cross AIDS Research Center
Dr Nurlan Silitonga
Angsamerah Institution
Dr Annette Sohn
TREAT Asia/AmfAR
Dr Tawesak Tanwandee
Coalition to Eradicate Viral Hepatitis in the Asia Pacific (CEVHAP)
Ms Sasiwimol Ubolyam
HIV Netherlands Australia Thailand Research Collaboration
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
13
Assembly Program Friday 15th January 2016 Day 1 (Queen Sirikit Convention Centre)
Time
Session
12:00 – 18:00
Registration Prof Praphan Phanuphak Thai Red Cross AIDS Research Center
16:00 – 16.15 Welcome Welcome to Bangkok and 1st Regional Network Assembly
16:15 – 16.15
14
Speaker
Mr Steven Kraus UNAIDS RST A/Prof Mark Boyd Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Opening Plenary
The Development of HIVNAT - a demonstration of collaboration, capacity and workforce development
Prof Praphan Phanuphak
Adapting WHO Global Guidelines for a regional response
Dr. Ying-Ru Jacqueline Lo
Role of Professional Societies in HIV, VH and Sexual Health
A/Prof Mark Boyd
Vietnam Clinical HIV/AIDS Society – the role of a professional society in Vietnam
Dr Nguyen Van Kinh
Pacific Society for Reproductive Health – perspectives from the Pacific
Dr Alec Akeroma
The role of a professional societies in harm reduction approaches
Prof Adeeba Kamarulzaman
17:00 – 17:30
What to expect from the Assembly – – goals and aims
A/Prof Levinia Crooks
17:30 – 19:00
Reception and Networking event - Bring along your Business Cards
Thai Red Cross AIDS Research Center
WHO, Western Pacific Regional Office
ASHM
Vietnam Clinical HIV/AIDS Society
Pacific Society for Reproductive Health
University of Malaya, Kuala Lumpur
CEO ASHM
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Assembly Program Saturday 16th January 2016 Day 2 - Chulalongkorn Hospital, Faculty of Medicine
Time
Session
08:30 – 08:45
Overview of how the day will proceed recap of yesterday’s session
Speaker
A/Prof Levinia Crooks – ASHM
08:45 – 10:00
Showcasing effective activities and collaborations examples from the region Facilitator – A/Prof Levinia Crooks, ASHM
08:30 – 10:00
Clinical education in prisons experiences in Indonesia
Dr Nurlan Silitonga
TREAT Asia/ASHM clinical collaboration
Dr Annette Sohn
Evolution of a regional clinical resource to be country specific
Dr Nguyen Van Kinh
Angsamerah Foundation
TREAT Asia/AmfAR
Vietnam Clinical HIV/AIDS Society Dr Kiat Ruxrungtham
Upskilling of HIVNAT’s Research Capacity
HIV-NAT, Thai Red Cross AIDS Research Center Ms Shanthi Noriega Minichiello
RTI/Thai Red Cross/HIVNAT Collaboration
Inform Asia: RTI Dr John Millan
Clinical mentoring in Papua New Guinea
Papua New Guinea Sexual Health Society / Collaboration for Health in Papua New Guinea Dr Arvin Chaudhary
10:00 – 10:30
Clinical collaboration in the Pacific Region
Oceania Society for Sexual Health and HIV Medicine
My Commitment to Cure Hepatitis C Coalition, Malaysia
Prof Rosmawati Mohamed
Collaboration between Clinical Units to provide a regional training program in Singapore a training curriculum in development
Dr Sophia Archuleta
Taking a regional approach a regional chapter of International Union of Sexually Transmitted Infections in Asia and the Pacific
Dr Somesh Gupta
How the Malaysian Liver Foundation approaches clinical professional development
Dr Nor Shahidah Khairullah
University Malaya Medical Centre
National University of Singapore HIV Programme
International Union of Sexually Transmitted Infections - Asia Pacific Region
Malaysian Liver Foundation
Morning tea break
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
15
Assembly Program Saturday 16th January 2016 Day 2 - Chulalongkorn Hospital, Faculty of Medicine
Time
Session
Speaker
Panel: Identifying professional needs & gaps 10:30 – 12:00
Facilitators: Prof Sharon Lewin, Peter Doherty Institute for Infection and Immunity, Melbourne Australia Dr Roy Chan, Action for AIDS, Singapore Panellists: Dr Tawesak Tanwandee, Dr Razia Pendse, Mr David Fowler, Mr Steven Kraus and Dr Annette Sohn
12:00 – 13:00 13:00 – 14:30
Lunch and Networking Workshops session Description: The workshops are aimed at synthesising what we have heard in the morning sessions into SMART$ strategies. These will be Specific, Meaningful, Action oriented, Realistic and Timely. They will also explore $ financial issues, potential support or funding opportunities.
Workshop 1: Research – Operations, Quality, Training, Promulgation Presented by: A/Prof Mark Boyd, ASHM Dr Nagalingeswaran Kumarasamy, YR Gaitonde Centre for AIDS Research and Education Workshop 2: Guidelines and Professional Standards Presented by: Dr Ying-Ru Jacqueline Lo, WHO, Western Pacific Regional Office Dr. Maria Isabel E. Melgar, AIDS Society of the Philippines 14:30 – 15:00 15:00 - 16:30
Afternoon tea break Workshop sessions Workshop 3: Developing Clinical Capacity Presented by: Dr Kiat Ruxrungthan, HIV-NAT, Thai Red Cross AIDS Research Center Dr Alec Ekeroma, Pacific Society for Reproductive Health Workshop 4: What do you need from your Laboratory and what it needs from you Presented by: Ms Sasiwimol Ubolyam, HIVNAT Dr Phillip Cunningham, St Vincents Hospital Sydney Limited
16:30 – 17:00
18:30
16
Reporting back from Workshops and discussing key issues.
Workshop facilitators
Networking dinner – Crowne Plaza Lumpini
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Assembly Program Sunday 17th January 2016 – Day 3 Chulalongkorn Hospital, Faculty of Medicine
Time
Session
09:00 – 09:30
Registration
Speaker
Dr Evy Yunihastuti (Delegate rapporteur)
09:30 – 10:30 Reflections on the 1st Regional Network Assembly
Dr Alec Ekeroma (AIAB Member) Mr Scott McGill (ASHM Secretariat)
Regional Network Activities and Collaborations - plans and suggestions 10:30 – 11.00
A/Prof Levinia Crooks ASHM
Morning Tea
Dr Ying Ru Jacqueline Lo WHO, Western Pacific Regional Office 11:00-11.45
Funding: Opportunities and Challenges
Mr Steven Kraus UNAIDS Regional Support Team A/Prof Mark Boyd ASHM
12:00
12:30
Closing session: Regional Network Next steps
A/Prof Mark Boyd ASHM Lunch
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
17
Session Information
The aims of the Assembly are: •
to bring together people who are involved, via professional societies or other associations, in clinical, research and professional workforce development in HIV, viral hepatitis and sexual health.
•
to share experiences on what has worked and
•
identify those areas where further capacity development or skills building is required
•
with the hope that by the end of the assembly we might be able to identify ways forward to identify ways to address these skills and capacity shortfalls. It will truly be a working meeting. We expect about 50 workforce development and professional organisations to be represented.
Session 1 Panel: Show casing effective activities and collaborations – examples 08:45 – 10:00, Saturday 16th January 2016 This session will showcase activities which have been conducted which address clinical, professional or research capacity development. The oral presentations in this session will be a maximum of 5 minutes and preferably no more than 3 slides. Not all projects could be showcased, and a number of other projects and activities are included in the Assembly handbook. The presentations will be delivered at the beginning of the session to allow for a substantial panel discussion. The presentations will focus on describing: •
the identified need and target population for the activity (both the immediate population served by or participating in the activity) and those who will benefit from the health care provider or researcher having better skills
•
the approach taken and the capacitation activity which was performed, perhaps include why this intervention was chosen
•
the impact of the intervention and how change was implemented and plans to do more of this or to sustain the benefit, and make an observation were else this might be useful, with a different professional type, in a different disease or location.
Facilitated discussion for session 1: •
Are there any questions for the presenters?
•
Have you done any evaluation?
•
The example you gave related to professional group A, do you think this could be extended to other groups?
•
There are very few trained HCW here, do you think this tasks could be performed by another less trained professional group and if so what support would they need?
•
Task shifting is looked on poorly by some professional groups how do you address that and how can you change critics to supporters?
18
•
What are the little things in your career which have really impacted the way you practice?
•
Mentoring can happen formally and informally, how do you introduce mentoring into a workforce?
•
Is there a way to make skills sharing something which is valued? What does that look like in your setting?
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Session Information
Session 2 Panel: Identifying professional needs & gaps 10:30 – 12:00, Saturday 16th January 2016 This session will attempt to articulate some of the major health workforce development needs from across the Asia and Pacific regions. It will specifically look at those issues which might be able to be addressed by professional societies, colleges and workforce agencies contributing to training, policy and guideline development and the provision of mentoring or professional support. Presenters in session 2 will look at the needs which they identify to respond to country and regional strategies to address HIV, viral hepatitis and sexual health. They and the panel will be asked to reflect on workforce shortages, skills shortages and roles which the professional might play in facilitating workforce capacity development and sustainability. Facilitated discussion for session 2: •
Are there any questions for the presenters?
•
How do you see training translating in to changes in practice?
•
How do we cause systems changes?
•
Is there a role for mentoring?
•
Are conferences the way to cause practice and system change?
•
If not what does cause this?
•
Can anything be achieved without a major influx of money and if so how?
•
How do we encourage leadership?
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
19
Session Information
Workshops: 13:00 – 14:30 and 15:00 - 16:30, Saturday 16th January 2016 The workshops are aimed at synthesising what we have heard in the morning sessions into SMART$ strategies. These will be Specific, Meaningful, Action oriented, Realistic and Timely Strategies. They will also explore $ financial issues, potential support or funding opportunities. Each workshop is facilitated by two people. The facilitators will provide examples of activities they have been involved in and work with participants to find out what needs are in the given areas and how these might be addressed. Participants who have a specific interest in gaining skills or in providing and sharing skills should be thinking about this beforehand and be prepared to discuss these in the workshops. The group will be asked to prioritise their strategies. Ideas from workshops will follow a common format and address: •
Activity title
•
Specific description
•
Rationale
•
Actions required and by whom
•
Where, when and for how many
•
Cost and potential funding sources
One of the facilitators for each of the workshops will report back to the whole group. The ASHM International Advisory Board will review these strategies in its meeting on Sunday morning with the view to identifying what activities they will prioritise. On Sunday morning when the meeting resumes the whole group will review the priorities. The discussion on Sunday Morning will focus on drawing together the proposed activities from Saturday. It will outline a program of work for the coming period. There will be a significant discussion about: •
the ongoing role for the Network
•
how organisations engage with the network
•
possible expansion of the network, and
•
who might be missing from this meeting
•
potential activities for the network and
•
support arrangements
A full report from the Assembly will be collated and distributed through the network and stakeholders.
20
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Members and Delegates Key Activities
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) ASHM is a peak organisation of health professionals in Australia and New Zealand who work in HIV, viral hepatitis and sexually transmissible infections. ASHM draws on its experience and expertise to support the health workforce and to contribute to the sector, domestically and internationally. ASHM is a professional, not-for-profit, member-based organisation. It supports its members, sector partners and collaborators to generate knowledge and action in clinical management and research, education, policy and advocacy in Australasia and internationally. It is committed to quality improvement, and its products and services are sought after by governments, members, health care workers and affected people. ASHM's dedicated membership, highcalibre staff and commitment to partnership assure its effectiveness in achieving its mission. ASHM works collaboratively and in partnership to prevent HIV, viral hepatitis and STIs, and to preserve and protect the health of those living with these infections. It aims to function as a cohesive and inclusive group of professionals, advancing its vision in a skilled, informed, compassionate and appropriate way. Australasian Society for HIV, Viral Hepatitis and Sexual health Medicine: Regional Twinning partnerships In July 2014, Melbourne hosted the International AIDS Conference (AIDS 2014). Globally, this conference is well-sponsored by key pharmaceutical companies, however key local conference partners and local companies wish to create an enduring legacy for AIDS 2014 regionally, with tangible ongoing benefits for Australia and New Zealand. Following a consultation with 6 pharmaceutical industry partners and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), the option of regional twining program between Australian and regional clinicians was selected to offer the opportunity to provide regional fellow clinicians access to new technology and information while allowing Australian fellow clinicians to learn from high caseloads, and complex clinical cases in middle/low-resource countries. Key achievements of the program include: Clinical placement by regional Fellow Clinicians in the twining Australia-based clinics in July 2014, regional fellows’ participation in the a number of courses and Twining visits by Australian Counterparts to regional Fellows’ clinics and institutions from January – November 2015. The twining program has contributed to capacity building and knowledge transfer between Australian and regional clinicians. This program has added value to address needs for ongoing professional development in the region, which is particularly important for those countries being asked to play a greater role in resourcing their HIV programs. The program has contributed to ongoing development of professional links, partnerships and collaboration between Australian and regional individuals, clinical services, organisations and associations.
National Center for HIV/AIDS, Dermatology and STD, Cambodia The National Centre for HIV/AIDS, Dermatology and STD Control is an operational unit of the Ministry of Health. It provides health sector policy development for HIV/AIDS and STDs, programme management, provincial support, coordination with other partners in the health sector, guideline development for HIV/AIDS components, national health sector plan evaluation and dissemination of epidemiology, behaviour and effective STD/HIV/AIDS prevention and care information. It conforms to the coordinating strategy of the National Aids Authority (NAA) and works in partnership with other Government Ministries, Donor Bodies and Provincial Health Departments. The Centre manages the disbursement of programme and government funds according to previously approved work plans, under its Strategic Plan. Subsequently, it monitors and reviews progress against those plans, taking action to achieve conformance where necessary. Additionally, NCHADS has responsibility for the management of the National Dermatology and STD Clinic
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
21
Members and Delegates Key Activities
AIDS Institute, University of Hong Kong, Hong Kong The AIDS Institute of the University of Hong Kong was established in November 2007 to take HKU in a new strategic direction in fighting this global epidemic and help to make it a leader in the region in AIDS research, education and prevention. Scientists at the AIDS Institute are fully committed to conducting basic and applied research that facilitates the understanding of AIDS pathogenesis and the development of effective AIDS vaccines. Activities in the Institute include: basic research to examine the virological and immunological mechanisms underlying HIV pathogenesis; new concept, design, preparation and laboratory testing of vaccine candidates for HIV and other infectious diseases; and monitoring the evolution of HIV epidemic in Hong Kong and in the region.
Indonesian Medical Association (IDI), Indonesia Joining Forces to Strengthen the Indonesian Health Workforce on HIV, Viral Hepatitis, and Sexual Health: A Collaboration between Angsamerah Institution, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), and the Indonesian Medical Association (IDI). In early 2013, ASHM has started collaborating with Angsamerah Institution with the purpose of maximizing ASHM’s contribution to its partners and members in Indonesia, particularly IDI. A key element of this collaboration has been a project titled “Strengthening the Indonesian Health Workforce – a collaboration between Angsamerah, ASHM and its Indonesian professional society partners”, which aims at equipping general practitioners, particularly from the private sector, with comprehensive basic knowledge related to the clinical management of HIV, STIs, viral hepatitis, tuberculosis and recreational drug use, thus strengthening the private sector’s contribution to the national sexual and reproductive health programs. Since July 2014, ASHM and Angsamerah Institution and IDI have been joining forces to provide general practitioners with a comprehensive training and support package, delivered through workshops and bedside teaching trainings at the two Angsamerah private clinics in Jakarta. The trainings engaged a wide range of experienced national experts on HIV and AIDS, STI, HIV and hepatitis co-infection, HIV and tuberculosis co-infection, addiction medicine, gender and sexuality, counselling, communication and self-motivation. This unique training and support package for general practitioners is linked to Angsamerah’s long-term goal of contributing to the reformation of the Indonesian health system by creating a network of 100 private clinics and practices across Indonesia (HAPPY Initiative), providing access to quality health care to an ever increasing number of patients. The training program, which aligns with the national HIV program, has been endorsed by the National AIDS Commission (KPAN), the Ministry of Health, and IDI.
22
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Members and Delegates Key Activities
Japanese Society for AIDS Research, Japan Our society has members around 2000 consisting of scientists working on basic, clinical and social issues and physicians, nurses, pharmacists and advocates. We share and discuss research results on HIV in all aspect of the disease including clinical, basic and social science. The annual meeting of our society reached 29th in 2015. In addition to the usual session of scientific presentation we invited experts in several different fields such as Dr.D.Ho, Dr.J.C. Martin and Dr.M.C.Cohen to learn recent advancement of HIV research. The prevention of HIV transmission was the major topic of the meeting. We started to revise our guideline and to discuss how to implement the PrEP strategy in Japan in line with the WHO recommendation. We have programs for the members to learn recent advancement of ART and clinical care of the patients with HIV infection as an advanced training course. The number of doctors who have been certified as Board Certified Member of the Japanese Society for AIDS Research since 2012 is 243 and nurses who have been certified as Board Certified Member of the Japanese Society for AIDS Research since 2012 is 91.
Malaysian Liver Foundation Hepatitis disease management programs in Malaysia Malaysia is a multi-ethnic country, with a population of 23 million, comprising a mix of Malays (50%), Chinese (33%), Indians (9%) and others (8%). It is made up of 14 states, each with variable standards of hygiene and sanitation. Like other countries in the region, viral hepatitis is an important public health problem in Malaysia. During the year 2000, approximately 4067 cases of viral hepatitis were seen in Malaysia. Of this, approximately 497 were due to hepatitis A and 2863 to hepatitis B. The Malaysian Liver Foundation is a charitable, non-profit organization dedicated to the diagnosis, treatment, and prevention of diseases of the liver. Its many activities, put forth to achieve its intended objectives, are mainly concerned with education, research, and training. This organization has been a key player, along with the MOH, in the combat against liver diseases, specifically viral hepatitis. As part of its education program, the MLF has introduced public screening for hepatitis A, B, and C, and aims to educate the Malaysian public on the symptoms associated with viral hepatitis and available treatment options. To help overcome this, the MLF has contributed to the Ministry of Health substantial data pertaining to seroprevalence of hepatitis A, B, and C. In 2000, the MLF, under its research arm, established the Molecular Research Laboratory (MRL) to alleviate the frustration that hepatologists and gastroenterologists were experiencing due to the lack of facilities for viral load testing in the country.
My Commitment to Cure Coalition, Malaysia “My Commitment to Cure� Coalition was established to drive a comprehensive national plan to enhance care and cure of patients living with viral hepatitis, focussing on Hepatitis C. This group, consisting of hepatologists and gastroenterologists, are committed to work in partnership and engage relevant stakeholders for a meaningful impact on viral hepatitis. The priority actions identified include strengthening data collection, enhancing hepatitis C detection, provide better linkage to care, optimising treatment, and forming partnership. Sourcing data on the Hepatitis C disease burden in the country is crucial to present and convince policy makers on the need for a coordinated national response to HCV and creating public awareness on the urgency for action in HCV control, however, all elements outlined in the WHO Global Hepatitis Framework will be needed to achieve a coordinated approach to combating hepatitis C.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
23
Members and Delegates Key Activities
Burnet Institute, Myanmar The Myanmar program utilises Burnet Institute’s global expertise to respond to malaria, tuberculosis and emerging infectious diseases as prioritised by the Myanmar Ministry of Health, building on, and collaborating with, our broader HIV and maternal, neonatal and child health programs. We advocate for, and help build, stronger health systems, community knowledge and skills to improve the health of women and children. Our programs respond to the Myanmar Ministry of Health’s MNCH Essential Service package to improve services and promote greater engagement of men in sexual, reproductive, maternal and child health. A new sectoral focus for our program from 2016, the Myanmar Government is prioritising the needs of adolescents in the area of sexual and reproductive health, primary and secondary education, vocational training and economic opportunity. Burnet Institute also recognises that disruption of encultured gender inequities can be addressed with this population to minimize gender-based violence. We will work on behavior change in this area, and on improving access to information and services for sexual and reproductive health. Programming for adolescents will be prioritised through schools.
Collaboration for Health in Papua New Guinea The Collaboration for Health in Papua New Guinea (CHPNG), works with relevant Government departments, the National Catholic AIDS Office and some NGOs in PNG. The Australasian Society for HIV Medicine (ASHM) is working in projects to build the local capacity of health care workers in PNG to fight the STI and HIV epidemic. The PNG Sexual Health Society is working in partnership with ASHM with providing clinical mentoring support to health facilities and facilitating STI and HIV trainings for health care workers mostly in rural Catholic health facilities in PNG. The Catholic health service is the largest non-governmental organisation supporting the government in delivering HIV care and treatment services in the country. In the last 3 years the collaboration of OSSHM, ASHM and PNGSHS has successfully delivered 3 HIV prescriber trainings conducted for Pacific Island doctors. The trainings were conducted at the Epeanda (Catholic) aid post a rural clinic in the Southern Highlands province of PNG. The facility is run by nurses only and is managing more than 850 HIV patients on ART.
24
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Members and Delegates Key Activities
Papua New Guinea Sexual Health Society The PNGSHS is a non for profit organisation, officially launched in 2006, whose members consist of sexual health professionals, general health professionals and others with a specific interest in sexual health in PNG. The Society evolved out of concerns that previous efforts aimed at issues related to sexual health were in reality, harm minimisation measures aimed at the failure of achieving good sexual health and were mainly aimed at the specific issues of sexually transmitted infections, including HIV. The Society recognises the need to promote sexual health as a positive entity, the right of all, and not just limited to addressing sexually acquired infections. The objects and purposes of the Society: 1.
To reduce the impact of STIs including the HIV epidemic by the use of established public health and scientific methods.
2.
To ensure optimal care and support for all STI and HIV infected individuals.
3.
To advance the science and best practice of STI and HIV related medicine.
4.
To facilitate liaison between community, public health, clinical and laboratory practitioners.
5.
To provide a forum for the development and expression of a multidisciplinary approach to all aspects of Sexual Health, STI and HIV medicine.
6.
To foster education for health professionals and the general public.
7.
To facilitate and promote a national research programme.
8.
To provide career assistance to members of the Society.
9.
To assist publication of papers, periodicals or books which the Society deems desirable for the promotion of its objectives.
10. To promote informed public discussion of issues related to Sexual Health, STI and HIV medicine. 11. To liaise with other national or international bodies whose objects are similar to those of the Society’s. 12. To meet any other needs of the members of the Society as deemed appropriate by the majority of members.
AIDS Society of Philippines, Inc. (ASP) AIDS Society of the Philippines, Inc. (ASP) is one of the leading Philippine AIDS organizations established in April 1996. ASP is a membership organization, whose individual members are experts and professionals from diverse fields in health and development, infectious diseases and public health, business, media and communications. The organization aims to prevent the further spread of HIV through advocacy work, training and research. ASP has successfully managed over 60 projects supported by international multilateral and bilateral agencies. Currently, ASP is a member of the Philippine NGO Council on Population, Health and Welfare (PNGOC), Asian Business Coalition on AIDS, AIDS Society of Asia and the Pacific (ASAP), and, at one time, the International AIDS Society (IAS). Since 1997, the ASP has conducted the biennial Philippine National Convention on AIDS, the only national convention in the country where various stakeholders meet on HIV and AIDS. ASP has conducted several scientific meetings graced by distinguished international experts. From 1997 to 2000, ASP conducted regional skills building workshops in Nepal, Vietnam, Malaysia and China for health workers. In 1997, ASP was the main organizer and acted as secretariat for the 4th International Conference on AIDS in Asia and the Pacific (4th ICAAP) with concurrent 12 skills building workshops. The conduct of the 4th ICAAP laid down what would become ASP’s pioneering work in HIV and AIDS advocacy through media. The media activities resulted in the launching of the AIDS Media Awards in 1999 and continued until 2003. AIDS Society of The Philippines was a sub-recipient of the Global Fund Round 6-HIV Project and recently the Global Fund New Funding Model for HIV Grant (2015-2017). Through this grant the ASP will be actively involved in prevention programs for MSM, TGs and PWIDs.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
25
Members and Delegates Key Activities
Communicable Disease Centre, Tan Tock Seng Hospital, Singapore For more than 100 years, our hospital through the CDC has always been at the forefront of major infectious disease challenges in Singapore. We were there when the community battled smallpox, plague, diphtheria, thyroid, cholera and malaria in the early 1900s, to HIV, Nipah virus, SARS and the threats of a flu pandemic in recent years. As we advance into its next century, our plans for the CDC remain the same – for it to continue its vital role and function in Singapore's public health system, with emphasis on research, training and education. Moving in tandem with medical advancement, science and technology, CDC will strive to stay abreast and relevant in supporting our community and Singapore. We provide consultation and treatment for the following: •
Community-Acquired Infections
•
Communicable Diseases
•
Epidemiology
•
HIV Infection / Acquired Immunodeficiency Syndrome
•
Infection Control
•
Infections in the Immunocompromised Host
•
Nosocomial Infections
•
Outbreak Management
•
Outpatient Intravenous Antibiotic
National Skin Centre Singapore - the Department of STI Control (DSC) clinic DSC (or Department of Sexually Transmitted Infections Control) Clinic is a specialist outpatient clinic for the diagnosis, treatment and control of Sexually Transmitted Infections (STIs) in Singapore. We are committed to the practice of medicine compatible with the highest professional and ethical standards. The DSC Clinic is funded by the Ministry of Health, Singapore, enabling us to provide our services at an affordable rate. Along with clinical care, DSC also works in area of research and STD/STI education. DSC provides support to healthcare workers in the field by providing training and developing guidelines for STI management.
National University Hospital Singapore HIV Programme The Program utilises the skills and expertise of a multidisciplinary team to provide holistic and specialised clinical care for HIV in the inpatient and outpatient setting. The program also educates healthcare workers, both within and outside of NUH, in providing inclusive and best practice care to people living with HIV/AIDS (PLHA). Additionally, the program conducts clinical, behavioural and operational research that aims to advance knowledge of HIV/AIDS and its impact on Asia
26
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Members and Delegates Key Activities
Action for AIDS, Singapore AFA is a non-governmental organisation dedicated to fighting AIDS/HIV infection in Singapore. It draws upon a network of healthcare professionals, advocates, educators and volunteers, to implement educational, testing, treatment and welfare programmes. AFA was formed in 1988 in response to the global and local spread of HIV infection. Formed in 1988, the organisation has evolved its functions and objectives – from the promotion of basic public awareness of HIV/AIDS and starting up support and assistance for persons living with HIV infection, to its present day role that requires greater coordination and collaboration, delivering complex prevention and care programmes in a globalised and connected society.
The Institute of Infectious Diseases and Epidemiology (IIDE), Singapore The Institute of Infectious Diseases and Epidemiology (IIDE) is the key referral center for HIV management in Singapore. Our HIV program aims to provide access for patients with HIV and AIDS in Singapore to treatment and psychosocial support by providing a wide variety of services. Apart from Infectious Disease physicians, the program includes other medical specialists such as dermatologist, ophthalmologist, endocrinologist and psychiatrist, and non-medical professions such as medical social workers, pharmacists, nutritionists and volunteer groups. Specific clinical HIV programs include Drug Adherence Program and Defaulter program, which aims to improve adherence to treatment regimen. The HIV Database project was set up to monitor and evaluate HIV care and treatment program in IIDE, to guide the improvement of our clinical services. Beside clinical programs, HIV research in IIDE had led to the development of in-house viral load assay to provide cheaper in-house assays for patients. Genotyping RĂŠsistance tests (GRT) and Baseline Viral typing developed in-house were also made available as a lab service for patients. In addition, our HIV program actively organizes a series of patient-centric events for within and outside of IIDE for the purpose of fund-raising and creating awareness.
National STD/AIDS Control Programme, Sri Lanka The National STD/AIDS Control Programme (NSACP) of the Ministry of Health, Sri Lanka provides leadership and technical guidance to all STD clinics and ART clinics in the country. It also provides comprehensive care for STIs including laboratory services and plays a major role in training of medical and other healthcare workers in HIV and STIs in Sri Lanka. Some of the specific functions of NSACP include carrying out HIV prevention interventions for key populations and vulnerable populations such as men who have sex with men (MSM), sex workers, drug users, Beach boys, migrant workers, incarcerated people and uniformed personnel. NSACP networks with over 30 STD clinics and 15 ART centers situated in the country. Provision of technical guidance, procurement of ART and other drugs and laboratory reagents is done by NSACP for all these clinics. Provision of testing facility for HIV and STIs are done through the national reference laboratory of NSACP. Currently HIV confirmatory test (Western blot test) is available only at the NSACP laboratory. Generation and dissemination of strategic information by conducting surveillance and surveys is another significant function of our organization. Annual report of NSACP which comprise of latest data on HIV and STIs, the official website and Facebook account of NSACP keep all stakeholders, both local and international, well informed on the current status. The other key activity of NSACP is to collaborate with the Postgraduate institute of Medicine of the University of Colombo is to produce specialists in sexual health and HIV medicine.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
27
Members and Delegates Key Activities
Sri Lanka College of Venereologists (College for Sexual Health and HIV Medicine in Sri Lanka) The vision of the college is to be the centre of excellence in preparing health professionals and providing professional services on sexual health, HIV medicine and related prevention and programme sciences in the global society. To achieve this, our main mission is to make opportunities and implement wide array of academic programmes to ensure quality professionals for healthcare and professional services for beneficiaries. Our main objectives are: 1.
To provide elective opportunities for postgraduate education in Venereology (award Pg Dip Ven, MD in Venereology)
2.
To promote and provide opportunities for scientific research, fellowships, networking and other learning (Promotion of E-learning, short courses, researches, and conferences, fellowships)
3.
To maintain professional development, competencies and practices among professionals in the field through various
4.
CPD activities (conduction of Journal clubs, guest lectures, case conference, case presentations, clinical picture stories, and also assist in portfolio development)
5.
To provide professional service and guidance to individuals and organizations (Majority of members are working as employees of the ministry of health, field specific guideline development, provision of consultancy services for NGOs,WHO, UNAIDS, GFATM)
The International Union against Sexually Transmitted Infections (IUSTI) The International Union against Sexually Transmitted Infections (IUSTI) was founded in 1923 and it is organized on both a global and regional basis. It is the oldest international organisation with the objective of fostering international cooperation in the control of sexually transmitted infections including HIV/AIDS. IUSTI is concerned with the medical, scientific, social and epidemiological aspects of sexually transmitted infections and their control. IUSTI is on the Roster of the United Nations Economic and Social Council. It is an Official Non-Government Organisation in Consultative Status with the World Health Organisation. IUSTI organizes frequent international and regional conferences on sexually transmitted infections. In the Asia-Pacific Region, the conference is held once every two years. 19th IUSTI Asia-Pacific Conference will be held at Okayama Convention Centre, Okayama, Japan from December 1 - 3, 2016. IUSTI conferences are generally well attended. The 18th IUSTI Asia-Pacific Conference was successfully held at Bangkok from 11-14 November 2014. There were 375 participants from 37 countries. IUSTI-AP has been organizing training courses in association with COTISSA in Thailand. IUSTI-AP has also formulated treatment guidelines particularly for MSM in the region. IUSTI publishes an indexed journal, Sexual Health (Impact Factor 1.368). IUSTI-AP is keen to collaborate with other organizations with similar interests.
28
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Members and Delegates Key Activities
Oceania Society for Sexual Health and HIV Medicine (OSSHM) The Oceania Society for Sexual Health and HIV Medicine (OSSHHM), a not for profit organization registered in Fiji, was first conceptualized by a group of 10 health care workers from the Pacific Island Countries and Territories (PICTs) at a Pacific meeting held at the ASHM conference in Melbourne, 2006. OSSHHM’s key mandate has been to ensure that health care workers who work in the field of STI/HIV and sexual health have increased access to comprehensive STI/HIV and sexual health care training, and relevant resources to assist with the delivery of evidence-based care. OSSHHM provides a network between health care workers providing STI/HIV and sexual health care in the Pacific. In addition, OSSHHM works to provide technical input in the development of regional and national guidelines and other relevant documents of interest. OSSHHM works closely in collaboration with a number of partners including The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) and The Papua New Guinea Sexual Health Society (PNGSHS). OSSHHM considers its relationship with partners integral to delivering quality and effective support to health workers in the Pacific. In partnership with ASHM and PNGSHS, OSSHHM has facilitated the capacity building of 15 HIV doctors in in HIV management and prescribing in 4 Pacific Island Countries. Capacity building activities took place in Mendi, PNG through training and clinical attachments which enabled the doctors to experience a high case load they would otherwise be unable to experience within their own countries. The training was facilitated by ASHM who then provided ongoing clinical mentorship to the 4 countries. This project has been highly successful as demonstrated by increased capacity of the doctors, who have delivered the training and provided mentorship to other health workers within their own countries.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
29
Country Profiles/Members & Delegates Information Australia
HIV An estimated 27,150 people in Australia are HIV positive, of whom an estimated 3,350 (12%) are unaware of their HIV-positive status. In Australia, HIV transmission continues to occur primarily through sexual contact between men. In 2014, 1,081 people were diagnosed with HIV. The number of newly diagnosed HIV infections in Australia has remained stable for the past three years, with 1 081 cases in 2014, 1 028 in 2013 and 1 064 in 2012. Of all HIV diagnoses made in Australia in 2014, 70% of transmissions occurred among men who have sex with men, 5% of transmissions were attributed to either male-to-male sex or injecting drug use, 19% of transmissions were attributed to heterosexual sex, and 3% of transmissions were attributed to injecting drug use. Of the estimated 23,800 (88%) people with HIV in Australia who were aware of their HIV-positive status at end of 2014, an estimated 17,470 (73%) were receiving antiretroviral (ARV) treatment. 92% of people accessing ARV treatment were estimated to have an undetectable viral load.
Viral hepatitis An estimated 210 000 people were living in Australia in 2013 with hepatitis B infection. An estimated 389 (300 – 635) deaths in 2013 were attributable to chronic hepatitis B infection. The estimated prevalence of chronic hepatitis B infection in the Australian population in 2013 was 0.97%. The per capita rate of diagnosis of hepatitis C antibody declined from 52.7 in 2009 to 46.3 per 100 000 population in 2013. The rate of diagnosis of hepatitis C antibody in the Aboriginal and Torres Strait Islander population was more than three times the rate in the non-Indigenous population in 2013. An estimated 230 000 people were living in Australia with chronic hepatitis C infection, including 80 000 with moderate to severe liver disease.
HIV/HCV co-infection It is estimated that approximately 13% of people with HIV are co-infected with hepatitis C virus. Main route of co-infection is injecting drug use however recent evidence also suggests cases of HIV/HCV co-infection due to high risk sexual contact.
STIs Chlamydia was most frequently reported STI in 2013 with 82,537 new cases. Population rate was 359 per 100,000 population, slightly lower than 2012 rate. Rate of infection was highest among 20-24 years old. Rate of gonorrhoea infection has increased recently with infection rate of 91 per 100,000 population in 2013. The rate of diagnosis of infectious syphilis among men increased to greater than 9.0 per 100 000 population in the years 2007 – 2009 and increased again from 9.0 in 2010 to 14.0 in 2013 whereas the rate among women remained stable at 1.0 per 100 000 population.
References: Annual Surveillance Report, 2014, HIV, Viral hepatitis and sexually transmitted infections in Australia, Kirby Institute https://kirby.unsw.edu.au/sites/default/ files/hiv/resources/ASR2014.pdf Dore, G. & Sasadeusz, J. (2006), Co-infection: HIV & Viral hepatitis a guide for clinical management. ASHM Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
30
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Name of your organisation
Name of the person completing this survey
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
A/Prof Mark Boyd, A/Prof Levinia Crooks and Beth Wilson
Name of the person representing your organisation who will be attending the 1st Regional Assembly A/Prof Levinia Crooks, Scott McGill, A/Prof Mark Boyd, David Fowler, Beth Wilson, Ash Chauhan
Please provide your website address www.ashm.org.au Describe the main purpose and function of your organisation (300 words max) ASHM is a peak organisation of health professionals in Australia and New Zealand who work in HIV, viral hepatitis and sexually transmissible infections. ASHM draws on its experience and expertise to support the health workforce and to contribute to the sector, domestically and internationally. ASHM is a professional, not-for-profit, member-based organisation. It supports its members, sector partners and collaborators to generate knowledge and action in clinical management and research, education, policy and advocacy in Australasia and internationally. It is committed to quality improvement, and its products and services are sought after by governments, members, health care workers and affected people. ASHM's dedicated membership, highcalibre staff and commitment to partnership assure its effectiveness in achieving its mission. ASHM works collaboratively and in partnership to prevent HIV, viral hepatitis and STIs, and to preserve and protect the health of those living with these infections. It aims to function as a cohesive and inclusive group of professionals, advancing its vision in a skilled, informed, compassionate and appropriate way.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections and Co-infections
What are your key programs? Clinical/technical education CME Training Guidelines development
What are the key issues for your country/region? Developing a self-sustaining and flexible workforce. Professional societies and professional development will need to play a central role in this capacitation.
Please list the type of professionals you provide training for: Doctors Nurses Allied health
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
31
Country Profiles/Members & Delegates Information Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (cont.)
What are the areas of need for the professionals you provide training for? (Please enter different answers per professional group. If the need is the same across all areas please only provide one answer. for example: Technical: laboratory, testing, management. Health promotion, advocacy, guideline and policy development. Training: introduction to HIV,HBV,HCV, STIs and advanced training in HIV,HBV,HCV, STIs ) Management - gaining organizational skills and if management is clinical, then not losing that clinical skill from the workforce as people move to management. Research and laboratory - gaining skill and the use of data and evidence to routinely increase quality, in even the most simple of processes and building the collection and evaluation of data in to routine practice. to build capacity to include new or updated testing based on new technology that includes monitoring of QA/QC (I.e. ability to sustain the testing and its quality). Clinical - skills development and skills sharing in a rapidly changing and devolving treatment environment. HCV - recognising and providing care to people who inject drugs is a policy challenge in some jurisdictions. This needs to be addressed a priority is to help overcoming stigma (Health promotion) and encouraging people to test. HBV - shifting the paradigm to one where the disease can be treated as opposed to entrenched Across all the infections - helping promote prevention in the key affected populations is an important goal.
Do you provide training for? General healthcare professionals
32
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Cambodia
HIV There are some 75,000 people living with HIV (PLHIV) in Cambodia in 2014. UNAIDS has estimated approximately 694 new infections in 2014.HIV prevalence in Cambodia among general population adults aged 15 to 49 was estimated at 0.7% in 2013. 2,600 deaths occurred in year 2014 related to AIDS. Incidence rate has decreased generally after 1998. However, along with the decline in HIV prevalence among the general population, it was noted that Key Populations such as Entertainment Workers (EWs), people who inject drugs, Transgender people (TG) and Men who have Sex with Men (MSM) has remained the target group that required special attention in the provision of prevention, care and treatment services. The prevalence of HIV among FEW were down from 20.8% in 2003 to 13.9% in 2010, HIV prevalence among MSM went down gradually from 2.6% in 2005 to 2.16% in 2010.in 2010, prevalence of HIV among TGs was 9.8%. Continued targeted and effective interventions and by maintaining the current high level of coverage of ART among PLHIV, Cambodia is poised to become the first low-income country to achieve virtual elimination of HIV transmission by 2020.At the end of 2014, 71% of PLWHA were receiving ART.
Viral Hepatitis There is very limited data on HBV and HCV infection in Cambodia. The most recent available data on prevalence of HBV and HCV infection was in 2002 with a prevalence of around 8%. The prevalence of HBs Ag positivity in donated blood between 2001 and 2010 ranged from 7% to 9% - much higher than the prevalence of anti-HCV antibody positivity which ranged from 1% to 3% over the same period. The prevalence of HBV and HCV infection in populations with high-risk practices such as sex workers, MSM and PWID is not known. However another study has suggested prevalence of HBsAg of 7.7% and the prevalence of anti-HCV 14.7% among blood donors. Availability of HBV and HCV testing is limited in Cambodia.
HIV/HCV Co-infection The prevalence of anti-HCV antibody in HIV patients attending ARV clinics in Cambodia is 7.6%, with range of 4.8% to 11%. Currently there is no national registry for HIV/HCV co-infections in Cambodia. There are national guidelines for management of HIV, which include recommendations for co-infection with viral hepatitis.
Sexually Transmitted infections (STIs) Data about STIs is available from STI sentinel survey conducted in 2005. Chlamydia and gonorrhoea were found to be more common among FSWs followed by MSM. Crude prevalence of chlamydia among FSW was 14% and among MSM was 7.1% (rectal and urethral), prevalence of gonorrhoea was12% among FSWs and 1.7% among MSM in 2005. The prevalence of syphilis was also common among FSWs at 2.3%.
References: UNAIDS, Country Profile, Cambodia, http://www.unaids.org/en/regionscountries/countries/cambodia Country Progress Report, 2015, UNAIDS, http://www.unaids.org/sites/default/files/country/documents/KHM_narrative_report_2015.pdf AIDS Data hub, Country profile, Cambodia, http://aidsdatahub.org/Country-Profiles/Cambodia HIV/Viral Hepatitis Co-Infection: Experience of Cambodia, http://www.health.com.kh/author_attachment/hiv_viral_hepatitis_coinfection_experience_from_cambodia.pdf 2005 Cambodia STI Prevalence Survey, http://www.nchads.org/Publication/SSS/SSS%202005.pdf
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
33
Country Profiles/Members & Delegates Information National Center for HIV/AIDS, Dermatology and STD, Cambodia
The National Centre for HIV/AIDS Dermatology and STDs (NCHADS) was established in 1998 following the amalgamation of the National Aids Programme (NAP) and the National STD and Dermatology Clinic. Since then, its primary purpose has been to respond to the HIV/AIDS epidemic through the implementation of HIV/AIDS Strategic Plans.
Name of the Organisation National Center for HIV/AIDS, Dermatology and STD
Please indicate which of the following best describes the nature of the organisation An organisation which provides professional or workforce development to health care workers
What conditions are covered by your organisation, tick all that apply HIV Sexual Health (sexually transmissible infections, venereology)
Jurisdiction, Country or Region covered by your organisation Cambodia
Organisation website address www.nchads.org Your role in the organisation Head of AIDS Care Unit
34
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Hong Kong
HIV As of September 2015, there are 7,534 PLWHIV and 1,626 people living with AIDS in Hong Kong. Reported cases of HIV have increased each year in Hong Kong since first reported incidence in 1984 with slight drop around 2010-11. Prevalence of HIV/AIDs is higher among males as compared to females with estimated 5,892 males living with HIV as compared to 1,453 women. Prevalence of AIDS is also high among males when compared to women. Prevalence of HIV/AIDS is high among people of Chinese background. People in the age group of 20-49 comprises as majority of the cases of HIV/AIDS with highest prevalence in age group of 30-39 years. Ratio of (heterosexual: homosexual/bisexual) sexually acquired HIV infection in men is 0.6:1 and AIDS is 1.4:1. Injecting drug use accounted for 4.6% and 3.9% cases of HIV and AIDS respectively. Coverage of PLWHA on ART is unknown.
Viral Hepatitis Number of acute reported hepatitis B virus infections has decreased over last decade from 121 cases in 2002 to 41 cases in 2014. Also seroprevalence of HBs Ag has decreased over past few years in different population groups, e.g. it dropped from 8% in 1990 to 0.8% in 2014 among blood donors. In antenatal mother prevalence of HBsAg was 6.2% in 2014 as compared to 10% in 1990s. Also there is a decreasing trend among pre-marital women and health workers. Prevalence rates appear to be highest among men when compared to females. From 1996-2014, total of 56 cases of hepatitis C were reported with one to twelve cases reported annually. In Hong Kong, HCV prevails in isolated communities. Data from blood donors suggests that prevalence of HCV infection is roughly 0.1%. Prevalence rates were highest among females when compared to men. HCV was found to be more common among IDUs (66.8%) and patients requiring blood/blood products transfusion.
HIV/HCV co-infection From 2000 to 2014, HCV/HIV co-infection among new patients attending ITC (Integrated Treatment Centre) ranged from 1.5% to 24.8%. While HCV infection is present in 1.2–6.3% of HIV/AIDS patients infected due to sexual contact, HCV was nearly universal in patients infected through drug injection. Prevalence rates appear to be higher in males as compared to females.
STIs In year 2014, total of 12,616 cases of STIs other than HIV/AIDS were reported in Hong Kong. Overall prevalence of STIs among males was higher when compared to females. Non-gonococcal urethritis was highest recorded STI with 348-0 cases followed by non-specific genital infections (2461) and gonorrhoea (1163). 41 cases of syphilis were reported, all in men. Male to female ratio for gonorrhoea was 6:1.
References: Hong Kong STD/AIDS Update, Vol. 21, No.2, Quarter 2 2015, http://www.info.gov.hk/aids/english/surveillance/stdaids/std15q2.pdf Surveillance of Viral Hepatitis in Hong Kong - 2014 Update Report, http://www.chp.gov.hk/files/pdf/hepsurv14.pdf
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
35
Country Profiles/Members & Delegates Information Department of Health, Hong Kong SAR
Name of your organisation
Name of the person completing this survey
Department of Health, Hong Kong SAR
Ada Lin
Name of the person representing your organisation who will be attending the 1st Regional Assembly? Ada Lin
Please provide your website address www.aids.gov.hk
www.hepatitis.gov.hk Describe the main purpose and function of your organisation (300 words max) Department of Health in Hong Kong is responsible for the control of HIV/AIDS in Hong Kong, which includes surveillance, health promotion, treatment and policy development. In addition, the Viral Hepatitis Preventive Service in our service also works with other services in the Department of Health for surveillance, publicity and control of viral hepatitis in the territory.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Co-infections
What are your key programs? Guidelines development, Clinical/technical education, HIV treatment
What are the key issues for your country/region? HBV burden among those born after the implementation of universal neonatal HBV vaccination programme in 1988
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers
Do you provide training for General healthcare professionals
36
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information ASIAHEP Hong Kong Ltd - Hong Kong
Name of the Organisation Asiahep Hong Kong Ltd
Please indicate which of the following best describes the nature of the organisation Non- governmental organisation active in health education relating to the liver and advocate for health policies suggested by WHA and WHO
What conditions are covered by your organisation, tick all that apply Viral hepatitis (hepatitis B or Hepatitis C), Reproductive health, Liver cancer
Jurisdiction, Country or Region covered by your organisation Hong Kong SAR
Organisation website address www.asiahep.org.hk
AIDS Institute, University of Hong Kong - Hong Kong
Name of the Organisation Aids Institute, University of Hong Kong
What conditions are covered by your organisation, tick all that apply HIV
Jurisdiction, Country or Region covered by your organisation Hong Kong SAR
Organisation website address http://www.euni.de/tools/jobpopup.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
37
Country Profiles/Members & Delegates Information India
HIV With estimated 2.1 million people living with HIV in 2013, India has the third largest HIV epidemic in the world. In 2014, it is estimated that 130,000 people died due to AIDS. However there is recent decline in death related to AIDS. Overall, India’s HIV epidemic is slowing down, with a 19% decline in new HIV infections (130,000 in 2013), and a 38% decline in AIDS-related deaths between 2005 and 2013. HIV epidemic is India is mainly heterogeneous and there are wide variations in the spread of epidemic in different geographical locations. Key population (KP) affected are female sex workers (FSWs), men who have sex with men (MSM) and people who inject drugs (PWID). Analysis of HIV trends among FSW has shown declining trends. Limited data is available about prevalence of HIV and STIs among transgender community in India; however some studies have indicated high rates of HIV prevalence among transgender people in some geographical locations. There are also concerns about potential HIV transmission among females who inject drugs and female spouses of PWID and MSM. National Aids Control Programme was developed in 1992 for HIV prevention and management. Currently this program is in stage IV (2012-14) with a goal to ‘accelerate reversal and integrate response’. In year 2013-14, it is estimated that 830,707 people are on antiretroviral therapy (ART). ART is provided free through public health sector.
Viral Hepatitis With 3.7% point prevalence, India is considered to have intermediate level of hepB endemnicity however some studies have sown prevalence of >8%. At one point in time, there are roughly 40 million HBV carriers. Every year 1 million Indians are at risk of HBV infection and about 100,000 people die due to HBV infection. Population prevalence of HCV infection in India is 1 to 1.5%. It is estimated that 12-18 million people are infected with HCV in India. Transmission through unsafe injection practices (hep B carriage and hep C infection at 46% and 38% respectively), unsafe sexual practices and mothers to infants is well established. However HCV transmission is predominantly through unsafe injection practices. Although HBV is major cause of chronic liver disease, cirrhosis and liver cancer in India, about 20% are also associated with HCV infection.
HIV/HCV and HIV/HBV co-infection A recent study conducted showed presence of HBV (15%) and HCV (8.3%) co-infections in HIV positive patients. There is no national register for HIV and viral hepatitis co-infection in India and hence data is based on researches conducted. Prevalence of HIV/HCV and HIV/HBV co-infection is high among IDUs in India.
STIs A study conducted in 2007 suggests that bacterial STDs like gonorrhoea and chancroid are showing declining trends while viral STDs like herpes genitalis and condylomata acuminata are showing upward trend. Epidemiological information about current trends is not available.
Reference:
38
UNAIDS, Country Progress Report, 2015 National AIDS Control Organisation, Narrative country progress report of India: Global AIDS Response Progress Reporting 2015 AusAid HRF, Country Report India, 2011 AIDS Data Hub, Country profile – India, http://aidsdatahub.org/Country-Profiles/India National Centre for Disease Control (NCDC) quarterly newsletter, January-March 2014, Vol 3, Issue 1 http://hepcresource.amjmed.com/Content/pdfs/IHCP/Dhiman_Future.pdf Chanda et al, 2013, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978987/ Thappa and Kaimal, 2007, Sexually transmitted infections in India: Current status (except human immunodeficiency virus/acquired immunodeficiency syndrome) 1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information YRGCARE Medical Centre - India
Name of the Organisation Dr.N.Kumarasamy, YRGCARE Medical Centre, CART Clinical Research Site
Please indicate which of the following best describes the nature of the organisation An organisation which provides professional or workforce development to health care workers
What conditions are covered by your organisation, tick all that apply HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Reproductive health,
Public health, Infectious diseases, tropical medicine Jurisdiction, Country or Region covered by your organisation Chennai, Southern India
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
39
Country Profiles/Members & Delegates Information Indonesia
HIV It is estimated that in 2014, there are 660,000 people living with HIV in Indonesia. Prevalence rate is 0.5% in adults aged 15 to 49. Of 660,000 people living with HIV, 230,000 are women aged 15 years and above and 14,000 children aged 0 to 14 years. 34,000 people have died due to AIDS by 2014. Approximately 69,000 new infections were diagnosed in year 2014. Unprotected sex particularly among people with high number of sexual partners and unsafe injecting behaviour were considered as dominant mode of transmission of HIV infection in Indonesia. However there is a shift to unsafe sexual behaviour becoming dominant cause of HIV infection transmission. Cumulative reported AIDS cases shows the majority was due to heterosexual transmission, rising from 37% (2001-2005) to 71% (2011), while infection from drug injecting use dropped from 53% to 34% during the same period. Indonesia has embraced a broad and comprehensive approach to the AIDS epidemic including prevention, care, support, treatment, and mitigation of social and economic impact. Currently coverage of ART is 8% in Indonesia.
Viral Hepatitis Indonesia has moderate to high endemicity for HBV with prevalence rate of 3% to 17% (HBsAg positive). According to the Health Ministry, more than 7 million people across 21 provinces (approximately 2%) had hepatitis C as of 2007. HCV is more common in IDUs. The government does not have national policies relating to screening and referral to care for hepatitis B or hepatitis C.
HIV/HCV co-infection In HIV infected patients, a study in a teaching hospital in Jakarta showed a high rate of hepatitis co-infection. Of 3,613 newly infected HIV patients tested for hepatitis serology in HIV clinic, anti-HCV was found in 67.9%. Intravenous drug use is main mode of transmission of HIV/HCV co-infection, however 9.3% of HIV/HCV co-infection were caused by heterosexual transmission.
STIs There is high prevalence of STIs among FSWs. In one study prevalence of STI among FSW was: gonorrhoea 10.6%, chlamydia 26.7%, Mycoplasma genitalium 12.4%, and trichomoniasis 22.6%. Prevalence of active syphilis was high among direct and indirect FSWs (7.5% vs. 3.1%, respectively). Prevalence of STIs is also high among MSM and male to female transgender in Indonesia.
References: UNAIDS Country Profile,Indonesia, http://www.unaids.org/en/regionscountries/countries/indonesia UNAIDS Country Progress Report, 2012, http://www.unaids.org/sites/default/files/country/documents//ce_ID_Narrative_Report.pdf AIDS data hub, Indonesia, http://www.aidsdatahub.org/Country-Profiles/Indonesia HIV/Viral Hepatitis Co-Infection: Experience of Indonesia, http://www.health.com.kh/author_attachment/hiv_viral_hepatitis_coinfection_experience_from_indonesia. pdf IUSTI, http://www.iusti.org/regions/asia-pacific/iusti_ap_bali_papers_part2.pdf
40
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Angsamerah Institution
Name of the person completing this survey Felix Neuenschwander
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr. Nurlan Silitonga and Felix Neuenschwander
Please provide your website address www.angsamerah.com
Describe the main purpose and function of your organisation (300 words max) Angsamerah is a renowned sexual and reproductive health institution based in Indonesia’s capital, Jakarta. Founded in 2007, Angsamerah Institution has established itself as an important player within the field of sexual and reproductive health in Indonesia and beyond. Its aim is to provide high quality, holistic, complete and accessible information and services for the promotion of better sexual and reproductive health, as well as for the prevention and treatment of HIV and AIDS and other sexually transmitted infections (STIs) in Indonesia. The core businesses of Angsamerah include the operation of private clinics providing high-quality and friendly health services to „key affected populations” and the general public, to serve as an incubator for other clinics, and public health consulting.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections, Sexual and reproductive health
What are your key programs? Clinical/technical education, Training, Clinical services
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV, STIs, Co-infections, Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers
What are the areas of need for the professionals you provide training for? Area 1: General Practitioners: Clinical knowledge and update (diagnostic and treatment) Area 2: General Practitioners: Management, how to effectively and efficiently manage a health-service Area 3: Private sector with focus on primary health care
Do you provide training for? General healthcare professional
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
41
Country Profiles/Members & Delegates Information Eijkman Institute for Molecular Biology - Indonsia
Name of the Organisation Eijkman Institute for Molecular Biology
Please indicate which of the following best describes the nature of the organisation? A research institution which provides professional development and research capacity building
What conditions are covered by your organisation? Viral hepatitis (hepatitis B or Hepatitis C) , Public health, Infectious diseases, tropical medicine
Jurisdiction, Country or Region covered by your organisation Indonesia
Organisation website address http://www.eijkman.go.id/
Ikatan Dokter Indonesia (IDI) Indonesian Medical Association Name of the Organisation Ikatan Dokter Indonesia (IDI) Indonesian Medical Association
What conditions are covered by your organisation? IDI is the national medical accrediting agency in Indonesia; all practicing clinicians are required to be members. IDI is generally represented, variously as presenter, facilitator, organiser and endorsing agency, in most CME programs in Indonesia. A range of professional bodies or colleges sit within IDI; e.g. PPHI (Indonesian Association for Study of the Liver) et al, with which ASHM has conducted partnerships and collaborative projects. See https://translate.google.com.au/translate?hl=en&sl=id&u=http://pphi-online.org/&prev=search IDI is also active in responding to national emergencies, providing medical and related services to communities affected by floods, fires, earthquakes etc. IDI established an HIV Secretariat when it formally engaged with the national HIV program and ASHM. That Secretariat was initially represented by 3 senior individuals who provided voluntary support and activity. Administrative roles were provided by 2 junior staff.
Jurisdiction, Country or Region covered by your organisation Indonesia
Organisation website address http://www.ididkijakarta.com/
42
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Japan
HIV/AIDS A total of 15,812 cases of HIV infection and 7,203 AIDS cases have been reported as of the end of 2013 by AIDS Surveillance Committee, Ministry of Health, Labour and Welfare. Until 2008, there has been an increase in number of reported cases of HIV and AIDS reached its peak in 2010, but this has largely level off since. This increase reporting can be attributed to increase in testing and awareness about tests. In 2013, 1,106 HIV infection cases and 484 AIDS cases were reported, an increase of 104 and 37 cases over the previous year, respectively. Dominant route of transmission is sexual contact. It accounts for roughly 87% of HIV cases and 80% of AIDS cases. While mother to child transmission and transmission through injecting drug use accounts for less than 1% of cases among all cases of HIV infection and AIDS reported. Homosexual contact accounts for 56.3% of all cases of HIV infection and 37.6% of AIDS cases, while heterosexual contact accounts for 28.0% and 36.3%, respectively. Approximately 70% of all cases of HIV infection are in their twenties or thirties. Also some regions in Japan show higher reporting of HIV/AIDS.
Viral Hepatitis It is estimated that more than 3 million people suffer from chronic hepatitis B or hepatitis C in Japan. Of these, 2 million people are thought to be infected with chronic hepatitis C, where it is thought to be fourth leading cause of death among men an fifth among females. About one-half and one-fifth patients with liver cirrhosis are infected with HCV and HBV, respectively. Only 10% of all cases of cirrhosis are ascribed to alcohol overdoses. For hepatocellular carcinoma (HCC), 70% of patients have serologic markers for HCV infection. The continuing increase in the total number of HCC cases in Japan can be attributed to an increase of HCC caused by HCV. Injecting drug use is attributed as main cause of HCV infection. Publicly funded treatment is available for hepatitis B and hepatitis C. Drugs for treatment of hepatitis B and hepatitis C are on national essential medicine list and are subsidized by government.
HIV/ HCV/HBV co-infection Approximately 19.2% of people who are HIV positive are thought to have co-infection with HCV. Even though Japan has low endemicity of HBV, chronic HBV infection among HIV-positive individuals is estimated to be approximately 10-fold higher than that in the general population.
STIs A study conducted in 2009 reports that there has been increase in incidence of STDs in Japan over last decade. Another study conducted in women suggests that overall prevalence of high risk HPV, C trachomatis, and N gonorrhoea was 24%, 5.9%, and 2.2%. According to same study, prevalence of STIs was high among younger age group when compared to older age group. Along with this, rate of prevalence of STIs is higher among commercial sex workers.
Reference: UNAIDS—HIV/AIDS TRENDS IN JAPAN, March 2015 Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology. 2010;53(1):39-43. GLOBAL POLICY REPORT ON THE PREVENTION AND CONTROL OF VIRAL HEPATITIS, Chapter 8: WHO Western Pacific Region Koike et al, 2007. Prevalence of coinfection with human immunodeficiency virus and hepatitis C virus in Japan. Hepatology Research, 37(1), 2-5
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
43
Country Profiles/Members & Delegates Information Japanese Society for AIDS Research
Name of your organisation
Name of the person completing this survey
Japanese Society for AIDS Research
Shuzo Matsushita MD, PhD
Name of the person representing your organisation who will be attending the 1st Regional Assembly Shuzo Matsushita MD, PhD
Please provide your website address shuzo@kumamoto-u.ac.jp
Describe the main purpose and function of your organisation (300 words max) We share and discuss research results on HIV in all aspect of the disease including basic, clinical and social science.
Please indicate which disease areas your organisation works with HIV, Co-infections
What are your key programs? CME, Guidelines development, Presentation and discussion of research results
What are the key issues for your country/region? Access to testing/diagnosis, HIV
Please list the type of professionals you provide training for: Doctors, Nurses, Other (please specify) Pharmacists
What are the areas of need for the professionals you provide training for? Area 1: advanced training in HIV and co-infections (HBV, HCV, STIs)
Area 2: guideline and new prevention strategies Area 3: anti-retroviral treatment and comorbidity in clinical practise Do you provide training for? Members only
44
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Laos
HIV It is estimated that currently 11,000 people are living with HIV in Laos, with prevalence rate of 0.29% among adults aged 15-49. The prevalence among adults has increased from 0.16% in 2003 to 0.29 % in 2014. Number of new infections in year 2014 is < 1000 and number of people died due to AIDS is estimated to be < 500. The highest prevalence of HIV can be found in key affected populations (KAP) primarily among men who have sex with men at 1.6%, followed by drug users at 1.5% and sex workers at 1.4%. Sexual activity is the primary mode of transmission, accounting for the majority of HIV transmission at 88% from 1990-2014. The second most common route of transmission is from mother to child (4.9%), but this figure may not represent the true picture because of limited data. The implementation of the National Strategic and Action Plan (NSAP) for HIV/AIDS and STI Prevention and Control 2011-2015 and the Law on HIV/AIDS Control and Prevention together with the development of the new NSAP 2016-2020 showed the Lao Government political commitment and support in responding to the HIV epidemic. At the end of 2014, 3336 people were on ART, with coverage rate of 30%.
Viral Hepatitis According to study conducted in 2007, seroprevalence of HBsAg positive blood donors was 8.7%. The prevalence among males (9.7%) was higher than in females (6.2%). The prevalence of anti-HCV positive blood donors was 1.1%, with no significant differences between males (1.1%) and females (1.0%). Dual infection with HBV and HCV was 0.12%.
HIV/HCV co-infection Recently, at the end of 2010, three main sites for care and treatment of HIV positive patients in Lao (Mahosot, Xethathirath and Savannnakhet hospitals) reported that 319 people tested for HCV antibody. The HIV-HCV co-infection was 0.6%. However some other study suggests HIV/HCV co-infection rate of 1.09%.
STIs FSWs, mobile population and drug users are considered as population at risk for STI acquisition. A study suggests that in 2004 infection rate of chlamydia and gonorrhoea were 33 and 18% respectively among FSWs. In 2009, approximately 31% of FSWs reported that they had experienced symptoms of STI in past 3 months. Current information about STIs is not available in general population.
References: UNAIDS Country Progress Report, 2015, Laos, http://www.unaids.org/sites/default/files/country/documents/LAO_narrative_report_2015.pdf AIDS Data Hub, Laos, http://www.aidsdatahub.org/Country-Profiles/Lao-PDR Jutavijittum et al, 2007, Seroprevalence of hepatitis B and C Virus infection among Lao Blood donors HIV/Viral Hepatitis Co-Infection: Experience of Lao PDR
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
45
Country Profiles/Members & Delegates Information Mahosot Hospital Ministry of Health, Laos
Name of the Organisation Mahosot Hospital Ministry of Health, Laos
Please indicate which of the following best describes the nature of the organisation An organisation that provide Health Care Services and workforce development to health care workers
What conditions are covered by your organisation, tick all that apply HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Reproductive health, Addiction medicine, harm minimisation, harm reduction, Infectious diseases, tropical medicine, Mental health, psychology, counselling, support, Paediatrics, pneumology and cardiology
Jurisdiction, Country or Region covered by your organisation This is a Tertiary Care Hospital & one of the 3 Referral Hospitals at national level, Laos
46
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Malaysia
HIV Malaysia is estimated to have about 91,848 people living with HIV (PLHIV) by end of 2014. During the same period, the national surveillance system had reported a cumulative of 105,189 HIV cases, 21,384 AIDS and 17,096 deaths related to HIV/AIDS giving total reported PLHIV of 88,093. 6,200 new infections occurred in 2014, with 9,000 AIDS related deaths in same year. Over period of 29 years, Malaysia has observed tremendous biomedical and behavioural advances in the HIV prevention, diagnosis, and treatment. As a result, there has been a significant reduction of new cases by almost half from 28.4 per 100,000 populations in 2002 to 11.7 cases per 100,000 populations in 2014. Malaysia is a country with concentrated HIV epidemic with infection rates remains high above 5% among key populations (KPs) especially among PWID, female sex workers, transgender and men having sex with men (MSM) population. By 2013, Malaysia has enjoyed almost 50% decline in new HIV cases since its peak in 2002 (6,978 cases). But in 2014, new cases have edged up from 3,393 in 2013 to 3,517. Monitoring, evaluation and reporting of Malaysiaâ&#x20AC;&#x2122;s HIV/AIDS program is conducted by Sector for disease control and prevention, Ministry of Health. Currently National strategic Plan (NSP) provides a common ground and guideline for comprehensive approach for HIV prevention and treatment. At the end of 2014, 21,654 PLWHIV were on ART.
Viral Hepatitis Prevalence rate of chronic hepatitis B is estimated to be in between 5-8% in Malaysia. Reported incidence of hepatitis B had decreased from 12.9/100,000 population in 2000 to 7.7/100,000 in 2004. It is also suggested that 50% of cases of hepatitis B are infective. The prevalence of hepatitis C virus (HCV) infection in Malaysia has been estimated at 2.5% of the adult population.
HIV/HCV Co-infection Currently no data is available about HIV/HCV co-infection.
Sexually Transmitted infections (STIs) In Malaysia, due to underreporting, under testing and asymptomatic nature of disease, exact size of the STIs is unknown. According to 2008 guidelines for management of STIs, incidence rate of gonorrhoea and syphilis had decreased consistently from 2000 t0 2005. However some repots suggests that there is an increasing trends of STIs especially for early syphilis, herpes genitalis and genital warts.
References: Aids Data Hub, Malaysia, http://aidsdatahub.org/Country-Profiles/Malaysia UNAIDS Country profile, Malaysia, http://www.unaids.org/en/regionscountries/countries/malaysia UNAIDS, Country Progress Report, 2015, Malaysia, http://www.unaids.org/sites/default/files/country/documents/MYS_narrative_report_2015.pdf McDonald et al, 2015, Projections of the Current and Future Disease Burden of Hepatitis C Virus Infection in Malaysia B DATOâ&#x20AC;&#x2122; DR. CHUA SOI LEK, MINISTER OF HEALTH MALAYSIA, AT THE 6TH LIVER UPDATE, PETALING JAYA, 21 JULY 2005 Malaysian Guidelines in the treatment of STIs, 2008, http://www.moh.gov.my/images/gallery/Garispanduan/malaysian_guidelines_in_treatment_of_STI.pdf
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
47
Country Profiles/Members & Delegates Information Malaysian Liver Foundation
Name of your organisation
Name of the person completing this survey
Malaysian Liver Foundation
DATO' DR. NOR SHAHIDAH KHAIRULLAH
Name of the person representing your organisation who will be attending the 1st Regional Assembly TAN SRI DATO'SERI DR.ISMAIL MERICAN,, DATO'DR.NOR SHAHIDAH KHAIRULLAH
Please provide your website address http://www.loveyourliver.org.my/
Describe the main purpose and function of your organisation (300 words max) The Malaysian Liver Foundation (MLF) or Yayasan Hepar Malaysia was registered in April 1996 as a non-profit, charitable organisation dedicated to educating the Malaysian public on liver diseases specifically chronic hepatitis, the various treatment options available locally and abroad. MLF is dedicated to the development of a voluntary body that will work towards improved care and treatment or Malaysians suffering from all types of liver diseases through research, in collaboration with international links and corporation with government, education, public seminars and patient self-help groups. The Malaysian Liver Foundation has very actively been campaigning in the creation of awareness among the public on the ways of preventing not only of hepatitis B but also the other forms of hepatitis. We have been giving numerous public forums nationwide whereby we inform the public on the ways of prevention which includes both avoidance of risk behaviour and vaccination. Thus far we have conducted numerous ‘hepatitis days’ in Malaysia including Sabah and Sarawak. Blood testing for hepatitis is also offered to individuals to detect those who may have infection with hepatitis B or C but who are not aware that they do.
Main Objectives •
To create nationwide awareness on the importance of caring for the liver as well as increasing the understanding of liver diseases in general;
•
To facilitate training of doctors throughout the country to enable them to diagnose, treat and help in the prevention of hepatobiliary diseases;
•
To conduct research in the field of hepatobiliary diseases with possible worldwide collaboration with established hepatobiliary centres;
•
To establish international linkages with similar organisations worldwide;
•
To help patients cope with diseases of the liver, gall bladder, bile ducts and pancreas;
•
To corporative with government and non-government organisations (NGOs) interested in the provision of service for patients suffering from liver diseases and to coordinate such efforts for the benefit of patients.
Please indicate which disease areas your Organisation works with HIV, Hepatitis B, Hepatitis C, Co-infections
What are your key programs? Clinical/technical education, CME, Training, Guidelines development, RESEARCH
48
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Malaysian Liver Foundation (cont.)
What are the key issues for your country/region? Access to care/treatment, Access to testing/diagnosis, HIV, HBV, HCV, Co-infections
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers
What are the areas of need for the professionals you provide training for? Area 1: TECHNICAL LAB TESTING Area 2: ADVOCACY Area 3: GUIDELINES AND POLICY
Do you provide training for? Members only, Fellows/Trainees, General healthcare professionals, Public
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
49
Country Profiles/Members & Delegates Information Malaysian Society for HIV Medicine
Name of your organisation
Name of the person completing this survey
Malaysian Society for HIV Medicine
Suresh Kumar, Current President
Name of the person representing your organisation who will be attending the 1st Regional Assembly Suresh Kumar
Please provide your website address www.mashm.net
Describe the main purpose and function of your organisation (300 words max) To provide a group identity and consensus for Health Care Providers in the affairs of caring for People Living with HIV/AIDS (PLWHA) in Malaysia. •
To provide and participate in education of HIV/AIDS and raising its awareness for the medical and allied professions, patients, schools and the public
•
To design and conduct programs to develop knowledge and skills of MASHM members in dealing with HIV/AIDS
•
To review prevention, counselling and treatment programs for PLWHA and their contacts
•
To promote, conduct and coordinate research on HIV/AIDS
•
To collaborate with appropriate government, non-government & professional agencies, corporations and public organizations in pursuance of the objectives above
Please indicate which disease areas your organisation works with HIV
What are your key programs? CME, Training, Guidelines development, Conduct National AIDS conference every 2 years
What are the key issues for your country/region? Access to care/treatment, Engaging key affected populations, HIV, HCV, STIs, Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health
What are the areas of need for the professionals you provide training for? Area 1: Drs: advanced training in HIV, STIs Area 2: Nurses: advanced training in HIV, STIs Area 3: Allied health: Introduction to HIV, stigma, discrimination
Do you provide training for? General healthcare professional
50
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information University of Malaya - Malaysia
Name of your organisation
Name of the person completing this survey
My Commitment to Cure Hepatitis C Coalition, Malaysia
Rosmawati Mohamed
Name of the person representing your organisation who will be attending the 1st Regional Assembly Professor Rosmawati Mohamed
Please provide your website address www.mycommitment2cure.com.my
Describe the main purpose and function of your organisation (300 words max) •
to raise awareness on the burden and consequences of Hepatitis C infection,
•
to educate on the benefits of early detection and the importance of linkage to care.
•
to work in partnership with relevant stakeholders in formulating and promoting strategies and key action plans towards Hepatitis C elimination
Please indicate which disease areas your organisation works with Hepatitis C
What are your key programs? Clinical/technical education, Public and healthcare professional awareness and campaigns
What are the key issues for your country/region? Access to care/treatment
Please list the type of professionals you provide training for: Doctors, Allied health
What are the areas of need for the professionals you provide training for? Area 1: Hep C screening, Health promotion, advocacy, engage policy makers to develop a costed national strategy for HCV
Do you provide training for Fellows/Trainees, General healthcare professionals
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
51
Country Profiles/Members & Delegates Information Myanmar
HIV Estimated rate of HIV prevalence among 15 years and older in Myanmar is 0.54% in 2014. Epidemiological modelling suggests that there are around 212,000 people living with HIV in Myanmar and 9,000 new infections occurred in 2014. In the same year approximately 10,000 deaths were related to AIDS. In 2000, Myanmar recorded highest number of people diagnosed with HIV. This has declined since then with decline in deaths related to AIDS. HIV epidemic is concentrated among men who have sex with men (MSM), people who inject drugs (PWID) and female sex workers (FSW). Rate of infection in key population is roughly as follows: FSW 6.3%, MSM 6.6% and PWID 23.1%. HIV prevalence between MSM and PWID aged 25 years and older is significantly higher when compared to their younger counterparts. Since 2012, HIV prevalence rates in FSW and MSM has decline but there is increase in prevalence rates among PWID. Myanmar government has demonstrated strong political commitment in collaboration with stakeholders to prevent HIV transmission, management and improving quality of life of people living with HIV. This is reflected in their National Strategic Plan (NSP). As of the end of 2014, ART coverage was 40% (85,626 people on ART).
Viral Hepatitis While the prevalence of HIV is stationary, that of HBV and HCV is increasing in Myanmar. Carrier rate of HBsAg among population in Myanmar is high with estimated rate of approximately 10-12%. One study suggests that overall prevalence of HCV infection was 11.6% with regional distribution; highest prevalence in western city (26.2%) with lowest in southern city (4.2%). Most HBV infections in Myanmar are transmitted vertically. HCV infections are common among IDUs.
HIV/HCV co-infection A cross-sectional analysis of large HIV care program in Myanmar from 2005-2012 indicated that sero-prevalence of HCV infection among HIV positive population was 5.3%. PWID are at the highest risk of HIV/HCV co-infection.
STIs Currently no information is available about STI epidemiology other than HIV in Myanmar
References: USAID Country Progress Report, Myanmar, 2015, http://www.unaids.org/sites/default/files/country/documents/MMR_narrative_report_2015.pdf USIAD Country Profile, Myanmar. AIDS Data Hub, Myanmar, http://www.aidsdatahub.org/Country-Profiles/Myanmar Zav et al, 2013, Prevalence of hepatitis C and B virus among patients infected with HIV: a cross-sectional analysis of a large HIV care programme in Myanmar Lwin et al, 2007, Hepatitis C virus genotype distribution in Myanmar: Predominance of genotype 6 and existence of new genotype 6 subtype WHO, 2010, Viral Hepatitis in the context of HIV in South-East Asia Region Khin, 2002, Control of Hepatitis B Viral infection in Myanmar: Public Health issues
52
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Burnet Institute - Myanmar
Name of your organisation
Name of the person completing this survey
Burnet Institute Myanmar
Phone Myint Win
Name of the person representing your organisation who will be attending the 1st Regional Assembly Phone Myint Win
Please provide your website address www.burnet.edu.au
Describe the main purpose and function of your organisation (300 words max) Burnet Institute Myanmar strives for effective public health intervention and research excellence in communicable and noncommunicable diseases, maternal, neonatal and child health, and adolescent health through strategic and functional partnerships with civil society, international agencies and national health programs. We engage with local partners and government to work with key affected populations to address HIV, sexually transmitted diseases and blood-borne viruses through prevention, care and treatment. The Myanmar program utilises Burnet Instituteâ&#x20AC;&#x2122;s global expertise to respond to malaria, tuberculosis and emerging infectious diseases as prioritised by the Myanmar Ministry of Health, building on, and collaborating with, our broader HIV and maternal, neonatal and child health programs. We advocate for, and help build, stronger health systems, community knowledge and skills to improve the health of women and children. Our programs respond to the Myanmar Ministry of Healthâ&#x20AC;&#x2122;s MNCH Essential Service package to improve services and promote greater engagement of men in sexual, reproductive, maternal and child health. A new sectoral focus for our program from 2016, the Myanmar Government is prioritising the needs of adolescents in the area of sexual and reproductive health, primary and secondary education, vocational training and economic opportunity. Burnet Institute also recognises that disruption of encultured gender inequities can be addressed with this population to minimize gender-based violence. We will work on behavior change in this area, and on improving access to information and services for sexual and reproductive health. Programming for adolescents will be prioritised through schools.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections, malaria
What are your key programs? Clinical/technical education, Training, Service provision and research
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV, STIs, Co-infections, Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Peer/community workers, counsellors, laboratory technicians
What are the areas of need for the professionals you provide training for? Area 1: Technical: laboratory, testing, management. Area 2: Training: introduction to HIV, HBV, HCV, STIs and advanced training in HIV, HBV, HCV, STIs Area 3: Health promotion, advocacy, guideline and policy development.
Do you provide training for? Fellows/Trainees, General healthcare professionals, community health workers
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
53
Country Profiles/Members & Delegates Information Mandalay PHHIV Networks
Name of your organisation
Name of the person completing this survey
Mandalay PLHIV networks
Dr. Sai Ko Ko Zaw
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr.Sai Ko Ko Zaw
Describe the main purpose and function of your organisation Networking, Advocacy, Representation care and support
Please indicate which disease areas your organisation works with HIV, Sexually Transmissible Infections, Tuberculosis
What are your key programs? Clinical/technical education, Training
What are the key issues for your country/region? Access to care/treatment, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV & Tuberculosis
Please list the type of professionals you provide training for: Peer/community workers
What are the areas of need for the professionals you provide training for? (Please enter different answers per professional group. If the need is the same across all areas please only provide one answer. for example: Technical: laboratory, testing, management. Health promotion, advocacy, guideline and policy development. Training: introduction to HIV,HBV,HCV, STIs and advanced training in HIV,HBV,HCV, STIs) Area 1: Introdcution to HIV Area 2: Active TB case finding Area 3: Home based care
Do you provide training for? Members only
54
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Papua New Guinea
HIV Estimated prevalence rate of HIV and AIDS among adults aged 15 to 49 is 0.7% at the end of 2014Estimated number of people living with HIV (PLHIV) is 37,000. Of these women aged 15 and above living with HIV are 19,000. Approximately 4,300 children under 14 years are living with HIV. ADIS related deaths were less than 1000 in 2014. Estimated 2,000 new cases were diagnosed in 2014. Rate of new diagnosis has decline since 1999 but has remain stable since last few years. It is thought that HIV epidemic in PNG is concentrated among certain geographical locations and certain groups. Main mode of transmission is heterosexual contact. Key population group includes male sex workers (MSW), female sex workers (FSW), and men having sex with men (MSM). Other modes of transmission include injecting drug use, perinatal transmission, body piercing, blood transfusion and other unidentified causes. National HIV prevalence rate among FSW is 19%. HIV prevalence rate among MSM in Port Moresby is 4.4%. Data about PWID and MSW is not available.
Viral Hepatitis The prevalence of hepatitis B infection in PNG is poorly recorded with no recent data available. It is considered to be a high prevalent region with assumed prevalence of greater than 5%. There is likely to be regional and geographic variation in this. Although data about hepatitis C is scares, one study suggested 2% seroprevalence rate in PNG. However all seroprevalent cases were negative on HCV-RNA testing suggesting clearance of hepatitis c virus.
HIV/HCV co-infection Currently no data is available about HIV/HCV co-infection in PNG.
STIs Prevalence of STIs among FSWs is higher than women or men in PNG. According to systemic review and meta-analysis conducted in 2010, rate of prevalence for chlamydia was 26.1% among FSWs when compared to men (20%) and women (24.8%). Rate of prevalence for gonorrhoea was 10%, 16.3% and 33% among men, women and FSWs respectively. Rate of syphilis was 12.9%, 7.9% and 31.1% in men, women and FSWs respectively. Data about prevalence of HSV2 and bacterial vaginosis was not available.
Reference UNAIDS, Country profile â&#x20AC;&#x201C; Papua New Guinea, http://www.unaids.org/en/regionscountries/countries/papuanewguinea AIDS Data Hub, Country profile â&#x20AC;&#x201C; Papua New Guinea, http://aidsdatahub.org/Country-Profiles/Papua-New-Guinea UNAIDS Country Progress Report, Papua New Guinea, 2014, http://www.unaids.org/sites/default/files/country/documents//PNG_narrative_report_2014.pdf Hepatitis B Free, Papua New Guinea, http://hepatitisbfree.org.au/current-projects/ Harrison et al, 2013, Infection Frequency of Hepatitis C Virus and IL28B Haplotypes in Papua New Guinea, Fiji, and Kiribati Vallely et al, 2010, The Prevalence of Sexually Transmitted Infections in Papua New Guinea: A Systematic Review and MetaAnalysis
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
55
Country Profiles/Members & Delegates Information The Papua New Guinea Sexual Health Society
Name of your organisation
Name of the person completing this survey
The Papua New Guinea Sexual Health Society
John Millan
Name of the person representing your organisation who will be attending the 1st Regional Assembly John Millan
Describe the main purpose and function of your organisation (300 words max) The PNGSHS is a non for profit organisation, officially launched in 2006, whose members consist of sexual health professionals, general health professionals and others with a specific interest in sexual health in PNG. The Society evolved out of concerns that previous efforts aimed at issues related to sexual health were in reality, harm minimisation measures aimed at the failure of achieving good sexual health and were mainly aimed at the specific issues of sexually transmitted infections, including HIV. The Society recognises the need to promote sexual health as a positive entity, the right of all, and not just limited to addressing sexually acquired infections. The objects and purposes of the Society: •
To reduce the impact of STIs including the HIV epidemic by the use of established public health and scientific methods.
•
To ensure optimal care and support for all STI and HIV infected individuals.
•
To advance the science and best practice of STI and HIV related medicine.
•
To facilitate liaison between community, public health, clinical and laboratory practitioners.
•
To provide a forum for the development and expression of a multidisciplinary approach to all aspects of Sexual Health, STI and HIV medicine.
•
To foster education for health professionals and the general public.
•
To facilitate and promote a national research programme.
•
To provide career assistance to members of the Society.
•
To assist publication of papers, periodicals or books which the Society deems desirable for the promotion of its objectives.
•
To promote informed public discussion of issues related to Sexual Health, STI and HIV medicine.
•
To liaise with other national or international bodies whose objects are similar to those of the Society’s.
•
To meet any other needs of the members of the Society as deemed appropriate by the majority of members.
Please indicate which disease areas your organisation works with HIV, Sexually Transmissible Infections, Tuberculosis, Co-infections
What are your key programs? Clinical/technical education, Training, Guidelines development
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, STIs, Co-infections, Tuberculosis
Please list the type of professionals you provide training for:
Do you provide training for?
Doctors, Nurses, Allied health, Peer/community workers
General healthcare professionals
What are the areas of need for the professionals you provide training for? Area 1: technical: guideline and policy development and clinical management of HIV and STIs Area 2: training: introduction and advanced training in HBV, HCV, HIV and STIs.
56
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Philippines
HIV As of the end of 2014, estimated 36,000 people are living with HIV. Prevalence rate among adults aged 15 years and above is <0.1%. Number of women aged 15 and above is estimated to be 4,100. Number of deaths attributed to AIDS was less than 500 in 2014. 6,400 new cases were diagnosed in 2014. Primary mode of HIV transmission is sexual contact accounting for 93% of cases since 1984. Before 2008, heterosexual contact was main mode of transmission but since then more cases have been diagnosed with homosexual contact (gay and bisexual men, men having sex with men). National prevalence rate of HIV among female sex workers (FSW) was 0.27% and MSM was 3.3% at the end of 2014. Prevalence rate of HIV has declined in FSW but has increased among MSM since 2009. In 2010, HIV transmission among people who inject drugs was detected in the Cebu City and has continually been spreading since then with rate of 53% in Cebu district at the end of 2014. 31% of PWID reported using sterile injecting equipment at last injection in 2014. Philippines National Aids Council (PNAC), Department of Health (DoH) – Philippines along with other organisations develop strategies and programs for surveillance and monitoring, education and prevention of HIV transmission and care for PLHIV. At the end of 2014, approximately 8,500 people were receiving ART.
Viral Hepatitis Prevalence of hepatitis B is high in Philippines. It is estimated that roughly 7.3 million Filipinos (16.7% of the adult population) are chronically infected with the hepatitis B virus (HBV). It is also suggested that prevalence is highest among 20-49 age group. According to Hepatology Society of Philippines, up to 1% population is affected with chronic hepatitis C virus (HCV).
HIV/HCV co-infection Currently no data is available about HCV/HIV co-infection in Philippines.
STIs In 2013, rate of syphilis among PWID and MSM was 4.8% and 2% respectively, with rate higher among people 25 years and older. National average rate of syphilis among freelance FSWs (3.2%) was higher when compared to registered FSWs (0.8%). According to consensus report (2000), rates of gonorrhoea, chlamydia, trichomonas and bacterial vaginosis were consistently higher among freelance FSWs when compared to registered FSWs and MSM.
Reference: UNAIDS, Country profile – Philippines, http://www.unaids.org/en/regionscountries/countries/philippines AIDS Data Hub, Country profile – Philippines, http://aidsdatahub.org/Country-Profiles/Philippines UNAIDS Country Progress Report, 2015, http://www.unaids.org/sites/default/files/country/documents//PHL_narrative_report_2014.pdf Hepatology Society of Philippines, 2013, Prevention and Control of Hepatitis B and Hepatitis C in the Philippines: A Call to Action
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
57
Country Profiles/Members & Delegates Information AIDS Society of Philippines
Name of your organisation
Name of the person completing this survey
AIDS Society of the Philippines, Inc.
Maria Cecilia C Anonuevo
Name of the person representing your organisation who will be attending the 1st Regional Assembly AIDS Society of the Philippines, Inc
Please provide your website address www.aidsphil.org
Describe the main purpose and function of your organisation (300 words max) AIDS Society of the Philippines, Inc. (ASP) is one of the leading Philippine NGOs established in April 1996 by its founding President, Dr. Ofelia T. Monzon, who pioneered investigative studies on HIV and AIDS at the Research Institute for Tropical Medicine in Alabang, Muntinlupa City, with SEC registration no. ANO96-01422. ASP is a membership organization, whose individual members are experts and professionals from diverse fields in health and development, infectious diseases and public health, business, media and communications. The organization aims to prevent the further spread of HIV through advocacy work. ASP has successfully managed over 60 projects supported by international multilateral and bilateral agencies such as the Philippine National AIDS Council (PNAC), The Ford Foundation, Rockefeller Foundation, Levi Strauss Foundation, UNFPA, UNAIDS, etc. Currently, ASP is a member of the Philippine NGO Council on Population, Health and Welfare (PNGOC), Asian Business Coalition on AIDS, AIDS Society of Asia and the Pacific (ASAP), and, at one time, the International AIDS Society (IAS). Since 1997, the ASP has conducted the biennial Philippine National Convention on AIDS, the only national convention in the country where various stakeholders meet on HIV and AIDS. Approximately 2,000 participants attended the national conventions. ASP also conducted three scientific meetings and workshops on ethical guidelines in AIDS investigation in the Philippines. From 1997 to 2000, ASP has also conducted skills building workshops for medical, non-medical workers, drug users and persons with HIV and AIDS. Currently, the AIDS Society of The Philippines is implementing the Global Fund – Transitional Funding Mechanism/ Interim Applicant Mechanism entitled “Sustaining the Gains of Essential Program Services of the Round 6 HIV Grant in the Philippines” as sub-recipient No. 1 for Prevention activities. There are 13 project sites for the prevention intervention namely Manila, Caloocan City, Pasay City, Pasig City, Quezon City, Angeles City, Cebu City, Danao City, Mandaue City, Cagayan De Oro and Davao City and the contiguous cities in National Capital Region. This project caters to Key Affected Population (KAP) of males having sex with males and people who inject drugs.
Please indicate which disease areas your organisation works with HIV, Sexually Transmissible Infections
What are your key programs? Clinical/technical education, Training, Publication of books & newsletter, peer education and counselling
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Access to testing/diagnosis, HIV, HBV, HCV, STIs,Co-infections, Tuberculosis
58
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information AIDS Society of Philippines (cont.)
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers, Key affected population (MSM, Sex workers,Transgender, PWID)
What are the areas of need for the professionals you provide training for? Area 1: Management of PLHIV patients Area 2: Health promotion and advocacies Area 3: Advance training in HIV HBV HCV and other
Do you provide training for? Members only, Fellows/Trainees, General healthcare professionals, Key affected population
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
59
Country Profiles/Members & Delegates Information Republic of Korea
HIV It is estimated that approximately 10,425 adults and children are living with HIV in 2013. Reported number of people living with HIV (PLHIV) in 2009 was 9,500. 1,013 new infected cases were recorded in year 2013. Data about number of deaths due to Aids is not available for 2013. Number of new cases reported has increased over years. 888 new cases were recorded in 2011 as compared to 1,013 reported in 2013. The primary mode of transmission of HIV cases reported from 1985 to 2007 was heterosexual sex at 51%, followed by homosexual sex at 33%. Over 75% of incidence occurred in age group of 20-49 with highest in age group of 30-39 years. It is estimated that key affected populations include men who have sex with men (MSM), sex workers and their clients and those populations at lower risk include female partners of MSM and partners of clients of sex workers. In 2008, 30% of new cases occurred in MSM. HIV prevalence is estimated at 6% among MSM. The Korea Ministry of Health and Welfares and the Korea Centers for Disease Control and Prevention (KCDC) run HIV/AIDS control activities at provincial and local levels. They work in collaboration with other private sector organisations and NGOs.
Viral Hepatitis HBV infection has decreased in the Korean population since the advent of vaccination programs. Rates of HBsAg carriers were 2.98% in 2010. There has been a significant decrease in rate of HBsAg carriers among 10-39 years old however viral persistence remains in older population. The annual prevalence of diagnosed hepatitis C was approximately 0.12% to 0.13% in Republic of Korea. However prevalence of hepatitis C has very high regional variation, with three regions in the southern coastal area of the Korean Peninsula identified as a high-prevalence cluster.
HIV/HCV co-infection Currently no data is available about HIV/HCV co-infection in Republic of Korea.
STIs According to some studies, number of reported cases of STIs has decreased between 2001 -2009. A study of male patients, performed at Seoul in 2011 has reported rates of 26.0% (112/430), 9.1% (39/430), 6.7% (29/430), 0.5% (2/430) 0.2% (1/430), and 0.2% (1/430), for Ureaplasma urealyticum, Mycoplasma hominis, Chlamydia trachomatis, Neisseria Gonorrhoea, Trichomonas vaginalis, and MG detection, respectively. Another study conducted among females between 2006-2012 detected Mycoplasma hominis in 62.1% of the positive specimens, Ureaplasma urealyticum in 28.4%, Chlamydia trachomatis in 23.1%, Trichomonas vaginalis in 7.8%, Mycoplasma genitalium in 6.5%, and Neisseria gonorrhoea in 2.1%.
Reference: UNAIDS, Country profile – Republic o Korea, http://www.unaids.org/en/regionscountries/countries/republicofkorea AIDS Data Hub, Country profile – Republic of Korea, http://aidsdatahub.org/Country-Profiles/Republic-of-Korea UNAIDS Progress Report, 2011, http://www.unaids.org/sites/default/files/country/documents//ce_KR_Narrative_Report%5B1%5D.pdf http://aidsdatahub.org/sites/default/files/country_review/republic_of_korea_country_review_2011_0.pdf Kim et al, 2013, Recent trends in hepatitis B virus infection in the general Korean population Kwon et al, 2014, Regional Distribution of Hepatitis C Virus Infection in the Republic of Korea, 2007–2011
60
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Singapore
HIV The prevalence of known people living with HIV (PLHIV) among the resident population aged 15 years and above was 0.15% in 2014. It is estimated that there were 6685 PLHIV at the end of 2014. Of these 1737 (26%) have died. 456 new cases were diagnosed in 2014. This is very similar to number of new cases diagnosed in 2013 (454 new cases) and 2012 (469). Population group affected with HIV epidemic is predominantly male. Male to female ratio is 10:1. Mode of transmission is mainly sexual, with 59% cases acquired through heterosexual contact and 39% through homosexual contact. As of the end of Dec 2014, only 2% of cases were reported to be acquired through intravenous drug use. Significant proportion of new cases present with advance stage of the infection. Ministry of Health, Singapore controls The National AIDS Programme. They collaborate with various private, community and government agencies. The programme focuses on HIV education and prevention in general as well as at-risk groups, providing care and support to PLHIV and reducing pool of undiagnosed people. Access to ART I available at low cost to PLHIV.
Viral Hepatitis Incidence of hepatitis B has declined since the introduction of vaccination program in Singapore from estimated 10 cases per 100,000 populations in 1989 to less than 2 per 100,000 populations in 2013. Overall prevalence of HBsAg was 0.3% among children 0-17 years and 3.6% among adults aged 18-79 years in 2010. It was lowest among young adults and highest among 5059 years age group. During the period 2005 to 2013, there were a total of 110 notified laboratory-confirmed cases of acute HCV infection, comprising 78 cases for the 3-year period from 2005 to 2007, and 32 cases for the 6-year period from 2008 to 2013.
HIV/HCV co-infection Prevalence of HIV/HCV co-infection is estimated to be <10% in Singapore. Prevalence is high among IDUs.
STIs Number of notifiable STIs, other than HIV, has decreased over few years. It was over 900 per 100,000 population in 1980 but it has decreased to 140 per 100,000 population in 2012. Among the five legally notifiable STIs, the overall incidence of chlamydia was the highest, followed by syphilis and gonorrhoea. The incidence of legally notifiable STIs was higher among males than female. In 2012, the male to female ratio for STIs was 1.7:1, and the overall rate was highest in 20-24 year age group.
Reference: UNAIDS, Country profile â&#x20AC;&#x201C; Singapore, http://www.unaids.org/en/regionscountries/countries/singapore AIDS Data Hub, Country profile â&#x20AC;&#x201C; Singapore, http://aidsdatahub.org/Country-Profiles/Singapore UNAIDS Country Progress Report, Singapore, 2015, http://www.unaids.org/sites/default/files/country/documents/SGP_narrative_report_2015.pdf Epidemiological News Bulletin, Ministry of Health, Singapore, 2014 Communicable Disease Surveillance in Singapore, Ministry of Health, 2012, https://www.moh.gov.sg/content/dam/moh_web/Publications/Reports/2013/HIV-AIDS%20 STIs%20Tuberculosis%20Leprosy.pdf Richard Guan, Hepatitis C infection in Singapore, http://www.singaporehepatitisconference.com/d1/18.%20HCV%20Current%20Practices%20in%20Singapore%20 (Richard%20Guan).pdf
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
61
Country Profiles/Members & Delegates Information National University Hospital Singapore HIV Program
Name of your organisation
Name of the person completing this survey
National University Hospital Singapore HIV Program
Jessica Michaels
Name of the person representing your organisation who will be attending the 1st Regional Assembly Jessica Michaels and Sophia Archuleta
Please provide your website address https://www.nuh.com.sg/umc/about-us/aboutus/division-of-infectious-diseases
Describe the main purpose and function of your organisation (300 words max) The Program utilises the skills and expertise of a multidisciplinary team to provide holistic and specialised clinical care for HIV in the inpatient and outpatient setting. The program also educates healthcare workers, both within and outside of NUH, in providing inclusive and best practice care to people living with HIV/AIDS (PLHA). Additionally, the program conducts clinical, behavioural and operational research that aims to advance knowledge of HIV/AIDS and its impact on Asia.
Please indicate which disease areas your organisation works with HIV
What are your key programs? Clinical/technical education, Training, and Research
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV, STIs, Co-infections and Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers and PLHA
What are the areas of need for the professionals you provide training for? Area 1: Technical Area 2: Heath Area 3: Training
Q11: Do you provide training for Fellows/Trainees, General healthcare professionals
62
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Communicable Disease Centre, Tan Tock Seng Hospital - Singapore
Name of the Organisation Communicable Disease Centre, Tan Tock Seng Hospital, Singapore
Please indicate which of the following best describes the nature of the organisation A medical or health professional College
What conditions are covered by your organisation, tick all that apply HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Public health, Addiction medicine, harm minimisation, harm reduction, Infectious diseases, tropical medicine, Mental health, psychology, counselling, support
Jurisdiction, Country or Region covered by your organisation Singapore
Organisation website address https://www.ttsh.com.sg
Your role in the organisation Senior Consultant Infectious Disease, Head (HIV Programme)
Name Lee Cheng Chuan
what is you main professional role, clinician, clinical educator, dentist, administrator etc. Clinician cum clinical educator (Adjunct Asso Professed at Yong Loo Lin School of Medicine, NUS
What conditions do you mainly work in? HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Infectious diseases, tropical medicine.
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
63
Country Profiles/Members & Delegates Information National Skin Centre Singapore - the Department of STI Control (DSC) clinic
Name of the Organisation National Skin Centre Singapore - the Department of STI Control (DSC) clinic
Please indicate which of the following best describes the nature of the organisatio STI clinic
What conditions are covered by your organisation, tick all that apply Sexual Health (sexually transmissible infections, venereology), STI epidemiology & research
Jurisdiction, Country or Region covered by your organisation Singapore
Organisation website address www.dsc-clinic.sg
Society of Infectious Diseases - Singapore Name of the Organisation Society of Infectious Diseases (Singapore)
Please indicate which of the following best describes the nature of the organisation A society with professional interests in infectious diseases
What conditions are covered by your organisation, tick all that apply HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Public health, Infectious diseases, tropical medicine
Jurisdiction, Country or Region covered by your organisation Singapore
64
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Action for AIDS - Singapore
Name of the Organisation ACTION FOR AIDS
Please indicate which of the following best describes the nature of the organisation AIDS NGO providing HIV related education, prevention, advocacy, testing and counselling and support
What conditions are covered by your organisation, tick all that apply HIV, Sexual Health (sexually transmissible infections, venereology)
Jurisdiction, Country or Region covered by your organisation Singapore
Organisation website address www.afa.org/sg
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
65
Country Profiles/Members & Delegates Information Institute of Infectious Diseases & Epidemiology
Name of your organisation
Name of the person completing this survey
Institute of Infectious Diseases & Epidemiology
Tan Mei Xuan
Name of the person representing your organisation who will be attending the 1st Regional Assembly Professor Leo Yee Sin
Please provide your website address https://www.ttsh.com.sg/IIDE/
Describe the main purpose and function of your organisation (300 words max) The Institute of Infectious Diseases and Epidemiology (IIDE) is a leader in managing and preventing infectious diseases. Leading through clinical excellence, compassionate care, innovative research and inspiring education, IIDE enables sharing of resources and expertise, and facilitates the broadening of clinical services and academic activities. Aiming to become the international leader in its field, IIDE collaborates with global partners, and is positioned as the precursor for the 330-bedded National Centre for Infectious Disease slated to open in the year 2018.
Please indicate which disease areas your organisation works with HIV, Dengue, Influenza, Hospital / Community Acquired Infections
What are your key programs? Clinical/technical education, Clinical and epidemiological research in Infectious Diseases
What are the key issues for your country/region? Engaging key affected populations, Dengue, Hospital / Community Acquired Infections
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health, Peer/community workers
Do you provide training for? Fellows/Trainees, General healthcare professionals
66
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Sri Lanka
HIV HIV prevalence rate among adults in Sri Lanka is <0.1%, with estimated 3,300 people living with HIV (PLHIV) by the end of 2014. Number of deaths due to AIDS was less than 200. Approximately 1000 women 15 years and over are living with HIV by the end of 2014. There is increasing trend in diagnosis of new cases of HIV and AIDS. Among reported HIV positive cases, approximately 25% of the cases were found to be with advanced disease (AIDS stage). Mode of transmission of HIV is mainly heterogeneous sexual contact accounting for approximately 78% of cases, followed by same sexual/Bisexual transmission amounting to 16%. Intravenous drug use and sharing of needles/syringes leading to HIV transmission is very low. The Mother to Child transmission of HIV is 5%. National HIV prevalence among FSW and MSM is 0.2% and 0.9% respectively. Prevalence of HIV among key population varies depending on geographical location. HIV prevalence is mainly concentrated among 25-49 years age group accounting for 77% of cases. National STD/AIDS Control Programme has developed partnerships with non-health sector organisations along with health sector organisations to develop strategies and planning and implementing programmes aimed at the prevention and control of STIs including HIV. It is estimated that in 2014, 644 people were on antiretroviral therapy.
Viral Hepatitis At present infection rates of HBV and HCV are low in Sri Lanka. Exact prevalence of HBV is unknown however according to a study conducted in once district, HBsAg carrier rate in the studied community was 2.5%. During 2009 and 2010, the HBV antibody prevalence in donated blood was found to be 0.1% and 0.2% respectively and for HCV antibody prevalence rate was found to be 0.3% and 0.4% respectively.
HIV/HCV co-infection Although routine screening of HCV is recommended for PLWHIV, availability of HCV testing is limited. According to available data as of the end of 2010, only 2 people were diagnosed with HIV/HCV co-infection.
STIs Data is routinely collected about STIs from people attending sexual health clinics in Sri Lanka. In year 2014, genital herpes was most commonly diagnosed STI followed by Candidiasis and non-specific cervicitis or urethritis. Each representing more than 10% of STIs diagnosed in 2014. Approximately 50% of people who attended sexual health clinic were diagnosed with STI. 7.7% of attendees had syphilis and 9.8% had genital warts in year 2014.
Reference: UNAIDS, Country profile â&#x20AC;&#x201C; Sri Lanka, http://www.unaids.org/en/regionscountries/countries/srilanka AIDS Data Hub, Country profile â&#x20AC;&#x201C; Sri Lanka, http://aidsdatahub.org/Country-Profiles/Sri-Lanka NATIONAL STD/AIDS CONTROL PROGRAMME, MINISTRY OF HEALTH, SRI LANKA, Annual Report 2013 Noordeen et al, 2015, A review of hepatitis B virus infection in Sri Lanka Manathunge at al, HIV /Viral Hepatitis Co-Infection: Experience of Sri Lanka National STI/Aids control programme, Sri Lanka, Ministry of Health
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
67
Country Profiles/Members & Delegates Information Sri Lanka College of Venereologists
Name of your organisation
Name of the person completing this survey
Sri Lanka College of Venereologists
Dr Ajith Don Karawita
Name of the person representing your organisation who will be attending the 1st RegionalAssembly Dr Ajith Don Karawita
Please provide your website address http://www.slcven.org/
Describe the main purpose and function of your organisation (300 words max) Sri Lanka College of Venereologists is the academic and authoritative professional body in the field of sexual health and HIV medicine, prevention and programme sciences in the country. It was established in 1995 for professional and scientific development of the specialty of Venereology. The college is a recognized body in the Ministry of Health and Postgraduate Institute of Medicine (PGIM), University of Colombo, Sri Lanka. Members of the college serve in the Ministry of Health and private sector in Sri Lanka as well as other countries such as UK and Australia. Members manage the Board of Study in Venereology of the PGIM, which trains doctors for the Postgraduate Diploma in Venereology and the Doctor of Medicine in Venereology.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections
What are your key programs? Clinical/technical education, CME, Training, Guidelines development
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, engaging key affected populations, Access to testing/diagnosis, HIV
Please list the type of professionals you provide training for: Doctors, Nurses, Peer/community workers
What are the areas of need for the professionals you provide training for? (Please enter different answers per professional group. If the need is the same across all areas please only provide one answer. for example: Technical: laboratory, testing, management. Health-promotion, advocacy, guideline and policy development. Training: introduction to HIV, HBV, HCV, STIs and advanced training in HIV, HBV, HCV, STIs) Area 1: STI knowledge Area 2: HIV medicine technical knowledge Area 3: Prevention and programme sciences
Do you provide training for? Members only, Fellows/Trainees, General healthcare professionals
68
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information National STD/AIDS Control Programme, Sri Lanka
Name of your organisation
Name of the person completing this survey
National STD/AIDS Control Programme, Sri Lanka
Ariyaratne Manathunge
Name of the person representing your organisation who will be attending the 1st Regional Assembly Ariyaratne Manathunge
Please provide your website address http://www.aidscontrol.gov.lk/web/index.php?lang=en
Describe the main purpose and function of your organisation (300 words max) The National STD/AIDS Control Programme (NSACP) of the Ministry of Health, Sri Lanka is the key agency responsible for the national response to HIV/AIDS in Sri Lanka and it networks with over 30 STD and ART clinics situated all districts of the country. NSACP provides leadership and technical guidance to all STD clinics and ART clinics in the country. Main objectives of NSACP are the prevention of transmission of Sexually Transmitted Infections (STIs) including HIV and provision of care and support for those infected and affected. NSACP is the sole provider of antiretroviral treatment and HIV care in Sri Lanka. It also provides comprehensive care for STIs including laboratory services and plays a major role in training of medical and other healthcare workers in HIV and STIs in Sri Lanka. Specific functions of NSACP include; •
Coordinating and participating in the national response to HIV epidemic
•
Carrying out HIV prevention interventions
•
Helping to create an enabling environment for STI and HIV prevention
•
Provision of clinical services for sexually transmitted Infections
•
Provision of treatment and care for people infected and affected by HIV
•
Provision of laboratory services for STI and HIV
•
Condom promotion for STI and HIV prevention
•
Provision of counselling services for STIs and HIV
•
Prevention of mother to child transmission of HIV and syphilis
•
Training and capacity building of health and non-health staff
•
Carrying out HIV and STI surveillance
•
Carrying out research in STI and HIV
•
Carrying out Monitoring and evaluation of STI and HIV services
•
Dissemination of Strategic information on STI and HIV
•
Generation of funds by preparation and coordination of Global Fund and other proposals
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
69
Country Profiles/Members & Delegates Information National STD/AIDS Control Programme, Sri Lanka (cont.)
What are your key programs? Clinical/technical education, CME, Training, Guidelines development, Management of Global Fund grant
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, STIs and Tuberculosis, Stigma and discrimination, wrong policy decisions, Lack of M&E culture
Please list the type of professionals you provide training for: Doctors, Nurses, Peer/community workers, Medical undergraduates, general public awareness creation
What are the areas of need for the professionals you provide training for Area 1: Clinical: Recent advances of clinical management, training of laboratory staff on newer testing methods, protocol
and guideline development
Area 2: Programme management: project management, monitoring and evaluation new concepts, use of strategic information for programmatic and policy decisions Area 3: M&E: Usage of common computer software, Data management, Data analysis, production of
Reports and creation of infographic
Do you provide training for? Fellows/Trainees, General healthcare professionals, Peer educators in prisons and key populations
70
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Taiwan
HIV As of the end of 2014, total number of people living with HIV and AIDS in Taiwan is estimated to be 29,665. Of these 99% are local Taiwanese people and 92% are male. In year 2014, there were 2,236 new cases of HIV and 1,387 new cases of AIDS were recorded. Estimated death toll due to AIDS is 4,600. The population affected with HIV/AIDS in Taiwan is young. Nearly 43% of people diagnosed with HIV are in age group of 20-29 years. 37.5% of people with AIDS are in age group of 30-39. Prevalence of HIV/AIDS is high among homosexuals accounting for 47.3% of HIV cases and 45.5% of AIDS cases. Further to this prevalence of HIV and AIDS are highest among unemployed population. Prevalence also varies geographically, highest being in New Taipei city. At the end of 2012, roughly 12,000 people received ART. Government has shown good response by implementing new programs for prevention and management of HIV/AIDS with other stakeholders.
Viral Hepatitis In 2011, the Taiwan centre for disease control, report approximately 2.5 million people living with hepatitis B and up to 700,000 people living with hepatitis C, a population prevalence of 10-15% for hepatitis B and 205% for hepatitis C. Taiwan for first country to implement nationwide hepatitis B immunization programme in 1983, with now coverage of over 95% of newborns being immunized. Treatment for Hep B and Hep C is free in Taiwan. Hepatitis C prevalence is higher among older people and shows specific geographical distribution. Hepatitis C is highly prevalent among IDUs.
HIV/HCV co-infection Prevalence of HIV/HCV varies among different key populations. One study found that prevalence rate of HIV/HCV co-infections among MSM and heterosexuals as 6.5% and 8.6% respectively. Another study indicates that prevalence of HIV/HCV co-infection among IDUs is 13.1%.
STIs In 2014, a total of 2,622 cases of gonorrhoea were reported. The ratio of males to females was 15:1. The majority was cases with age group of 25 to 34 years old (42.1%). In 2014, over 7,000 cases of syphilis were reported, with incidence higher among males and increasing over last 10 years. There are also studies which suggest that incidence of STIs especially Syphilis is raising among HIV positive people.
References: http://homepage.ntu.edu.tw/~ntuidrec/file/20130913/1-5%E9%99%B3%E6%98%B6%E5%8B%B3.pdf Centre for Disease Control, R.O.C., Taiwan, HIV/AIDS Report, 2014. Asia Pacific Viral Hepatitis Policy Survey and Assessment: Taiwan, 2013. Yen et al, 2012, Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan Sun et al, 2012, Recent Hepatitis C Virus Infections in HIV-Infected Patients in Taiwan: Incidence and Risk Factors
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
71
Country Profiles/Members & Delegates Information Thailand
HIV Prevalence of HIV among adults aged 15-49 years is estimated to be 1.1% in 2014, with estimated 450,000 people living with HIV (PLHIV). 19,000 people died due to AIDS in 2014. It is estimated that approximately 190,000 women aged 15 years and above are living with HIV and 6,900 children between 0-14 years are living with HIV at the end of 2014. 7,900 new infections occurred in year 2014. Overall there is a decline in new infections and death rate related to AIDS. HIV prevalence is concentrated among female sex workers (FSW), male sex workers (MSW), men having sex with men (MSM) and people who inject drugs (PWID) in Thailand. National HIV prevalence among PWID is highest with 25.2% followed by MSM at 7.1% and FSW at 2.2% in year 2014.Rate of HIV prevalence among KPs has decline over 2001-14. Rate of condom use at last sex and uptake of HIV testing has increased over last few years. 80% of PWID reported using sterile injecting equipment at last injections in year 2014. Thailand has committed to end AIDS epidemic by 2030. National AIDs Strategic Plan is developed by The Cabinet and National Aids Committee that will enable the country to achieve the ending AIDS targets by 2030. 271,652 PLHIV are on ART with coverage of 61%.
Viral Hepatitis Thailand is considered to have high prevalence of hepatitis B (>8% in general population). It is estimated that prevalence of hepatitis B varies in range of 4% to 13%. Prevalence of hepatitis B is high among MSM. Seroprevalence of HCV infection varies from region to region from about 1% in Bangkok to about 5-6% in north and northeast regions.
HIV/HCV co-infection Prevalence of HCV and HIV co-infection is approximately 7-8% in Thailand. Prevalence is highest among IDUs. Estimated HIV/HCV co-infection rate among IDUs in Thailand is 88-96%.
STIs Trend for reportable STIs increased on a national level from 2002 to 2009 (25.2 / 100,000 population in 2002 to reach 37.22 / 100,000 population, in 2009). Gonorrhoea is the most commonly reported STI followed by NGU and syphilis. Rates of LGV and chancroid are in decline since 1989 and now rarely reported. Gonorrhoea is still the most commonly reported STI in Thailand (5.08 / 100,000 population in 2000 to 11.33 / 100,000 population in 2009). Syphilis increased slightly from 2.71 / 100,000 population in 2000 to 3.27 / 100,000 population in 2009. Nongonococcal urethritis (NGU), July 11 www.iusti.org 4 the second most commonly reported STI in Thailand fell slightly from 6.2 / 100,000 population in 2000 to 4.09 / 100,000 population in 2009.
Reference: UNAIDS, Country profile â&#x20AC;&#x201C; Thailand, http://www.unaids.org/en/regionscountries/countries/thailand AIDS Data Hub, Country profile â&#x20AC;&#x201C; Thailand, http://aidsdatahub.org/Country-Profiles/Thailand THAILAND AIDS RESPONSE PROGRESS REPORT, 2015, http://www.unaids.org/sites/default/files/country/documents/THA_narrative_report_2015.pdf Linkins et al, 2013, Hepatitis A and hepatitis B infection prevalence and associated risk factors in men who have sex with men, Bangkok, 2006-2008 STI Global Update, IUSTI, http://www.iusti.org/newsletter/IUSTI_Global_Update_2011_2.pdf
72
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Thai AIDS Society â&#x20AC;&#x201C; Thailand
Name of the Organisation Thai AIDS Society
Please indicate which of the following best describes the nature of the organisation A professional society, representing health care professionals
What conditions are covered by your organisation, tick all that apply HIV, Viral hepatitis (hepatitis B or Hepatitis C), Sexual Health (sexually transmissible infections, venereology), Reproductive health, Public health, Mental health, psychology, counselling, support
Jurisdiction, Country or Region covered by your organisation Thailand
Organisation website address www.thaiaidssociety.org
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
73
Country Profiles/Members & Delegates Information Timor-Leste
HIV It is estimated that around 464 people are living with HIV in 2014. Of these, 227 are women above 15 years. Prevalence rate in Timor-Leste is quite low with 0.08% among 15 years and over. There were 89 new infections in 2014 (46 men and 43 women). 7 people died due to AIDS in 2014. Cumulative death toll due AIDS is estimated to be 63 in 2014. Modelling data also suggests a rising trend of the HIV prevalence and incidence in the country in the next several years. HIV prevalence is concentrated among female sex workers (FSW) and Men having sex with men (MSM). Data about people who inject drugs (PWID) is unavailable. Nationwide HIV prevalence among FSW is 1.5% and MSM is 1.3%. HIV prevalence among KPs is not evenly distributed and shows geographical variations. National Aids Programme (NAP) in collaboration with the National Commission to Combat HIV and AIDS in Timor-Leste (CNCS-TL) implemented the National HIV/AIDS Strategic Plan (2011-2015) (HIV NSP). Aim of tis plan is to “reduce STI and HIV/AIDS mortality and morbidity in Timor-Leste by enhancing related prevention and treatment services”. At the end of 2014, 173 PLHIV are on ART.
Viral Hepatitis Timor-Leste has high prevalence for hepatitis B. Data about prevalence of hepatitis C is currently unavailable. Data available from year 2011 suggests prevalence of hepatitis B in key population groups (MSM, FSW, Clients of sex workers and uniformed personnel) with geographical distribution. Data collected by Ministry of Health shows that 8.3% of FSW, 10.23% of MSM, 14.4% of clients of sex workers and 14.8% of uniformed personnel have chronic Hep B infection.
HIV/HCV co-infection Currently there is no data available about prevalence of hep C in Timor-Leste.
STIs Timor-Leste has high prevalence sexually transmitted infections in key population groups. In year 2011, 9.8% of FSW were positive for syphilis, and 1.5% was positive for Chlamydia. In the same year among MSM, prevalence rate of syphilis and chlamydia were 7.1% and 3.1% respectively. STIs were higher among clients of sex workers than any other group with prevalence rate of syphilis and chlamydia being 16% and 3% respectively. Prevalence rate for syphilis was 13.9% among uniformed professional. Data about prevalence of gonorrhoea is unavailable.
Reference: UNAIDS, Country profile – Timor Leste, http://www.unaids.org/en/regionscountries/countries/timor-leste AIDS Data Hub, Country profile – Timor Leste, http://aidsdatahub.org/Country-Profiles/Timor-Leste Global AIDS Response Progress Report Timor-Leste, MoH, 2014 IBBS Survey, 2011, Timor-Leste, http://www.aidsdatahub.org/sites/default/files/documents/IBBS_2011_Report_Timor_Leste.pdf
74
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Country Profiles/Members & Delegates Information Vietnam
HIV There are approximately 256,000 people living with HIV (PLHIV) in 2014 in Viet Nam. Prevalence rate among adults aged 15-49 years is 0.5%. Approximately 77,000 women aged 15 years and above are living with HIV. 5,300 children between 0-14 years are thought to have HIV. In year 2014, 11,000 people die due to AIDS in Viet Nam. Rate of new infections is declining and rate of PLHIV is increasing. HIV epidemic is concentrated primarily among female sex workers (FSW), people who inject drugs (PWID) and men having sex with men (MSM). Also increasing number of new infections is occurring between intimate partner relationships. In 2013, the greatest number of new infections occurred among men who share needles while injecting drugs and between high-risk men and their long-term female sexual partners; 45% and 28% respectively. Sex work was related to 18% of new infections followed by sex between men for 5%. Over the past 25 years, government of Vietnam along with stakeholders has made significant progress in preventing new infections, reducing AIDS-related deaths, and gradually scaling up harm reduction interventions and treatment and care in highburden provinces. Currently antiretroviral therapy coverage is 37% (93,262) in Vietnam.
Viral Hepatitis Vietnam has high prevalence of hepatitis B, ranging from 10 – 15%. It is estimated that roughly 8.6 million people are living with hepatitis B. Prevalence of chronic hep B infections is higher among males than in women. Main route of transmission of hepB infection in Viet Nam is mother to child. Prevalence of hepatitis C infection in Vietnam is low in general population, ranges from 1.7% in North to 4.2% in South. However it is more concentrated among PWID. It is estimated that up to 97% of people who inject drugs have been infected with hepatitis C virus.
HIV/HCV co-infections People who inject drugs have higher prevalence of HIV/HCV co-infection. According to a recent study conducted, HIV/HCV coinfection was prevalent among 35.4% of people seeking treatment. HIV/HCV co-infection was high among age group 30-39 and males with injecting drug use as the predominant mode of transmission.
STIs In Vietnam, reported number of STIs increased more than six-fold between 1996 and 2010. Key population group affected are MSM, FSW and PWID. In 2009, gonorrhoea and chlamydia were most reported STIs among MSM. In the same year, chlamydia was most reported STI among street based and venue based SWs followed by syphilis and gonorrhoea.
Reference: UNAIDS, Country profile – Vietnam, http://www.unaids.org/en/regionscountries/countries/vietnam AIDS Data Hub, Country profile – Viet Nam, http://aidsdatahub.org/Country-Profiles/Viet-Nam Optimizing Viet Nam’s HIV Response: An Investment Case October, 2014 http://www.wpro.who.int/vietnam/topics/hepatitis/factsheet/en/ http://www.wpro.who.int/vietnam/topics/hepatitis/factsheet_hepc/en/ Huy et al, 2014, http://www.hindawi.com/journals/art/2014/581021/
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
75
Country Profiles/Members & Delegates Information Vietnam Clinical HIV/AIDS Association (VCHAS)
Name of your organisation
Name of the person completing this survey
Viet Nam Clinical HIV/AIDS Association (VCHAS)
Nguyen Van Kinh
Name of the person representing your organisation who will be attending the 1st Regional Assembly Viet Nam clinical HIV/AIDS Associate
Please provide your website address www.vchas.org
Describe the main purpose and function of your organisation (300 words max) • Clinical education and training, • Information exchange, • Research, and • National and international cooperation
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Tuberculosis, Co-infections, infectious diseases
What are your key programs? Clinical/technical education, CME, Training, Guidelines development, Technicians assistants
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV and Lab diagnosis
Please list the type of professionals you provide training for: Doctors, Nurses, Laboratory technician in ID and HIV diagnosis
What are the areas of need for the professionals you provide training for? Area 1: Advanced training in HIV, HBV, HCV and Laboratory
Do you provide training for Members only, Fellows/Trainees
76
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Regional Organisations Australasian Society for Infectious Diseases
Name of your organisation
Name of the person completing this survey
Australasian Society for Infectious Diseases
Krispin Hajkowicz
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr Josh Hanson
Please provide your website address http://www.asid.net.au/
Describe the main purpose and function of your organisation (300 words max) The aims of ASID are to: •
Advance postgraduate education in infectious diseases in Australasia and internationally;
•
Promote research in all aspects of infectious diseases; and
•
Advocate for sound and evidence-based public health policy in matters related to infectious diseases.
Membership encompasses Infectious Diseases Physicians, Clinical Microbiologists, Scientists, Infection Control Practitioners, Public Health Physicians, Sexual Health Physicians, Veterinarians and others eminent in the field of infectious diseases. ASID has constituted several Special Interest Groups which bring together members with interests in Paediatric infections, Hospital Infection Control, Mycology and Viral Hepatitis. It has also established a Clinical Research Network and a New Zealand Committee.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections, General infectious diseases, microbiology, clinical trials, infection control
What are your key programs? Clinical/technical education, CME, Training, Guidelines development, Policy, Advocacy
What are the key issues for your country/region? Engaging key affected populations, Access to testing/diagnosis, HBV, HCV, Multi-resistant infections
Please list the type of professionals you provide training for: Doctors, Allied health, Early career scientists
What are the areas of need for the professionals you provide training for? Area 1: Clinical: HIV, HBV, HCV, STIs Area 2: Lab: HIV, HBV, HCV, STIs Area 3: Research: HIV, HBV, HCV, STIs
Do you provide training for Members only, Fellows/Trainees
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
77
Regional Organisations Australasian Sexual Health Alliance (ASHA)
Name of your organisation
Name of the person completing this survey
Australasian Sexual Health Alliance
Nikitah Habraken
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr David Lewis
Please provide your website address http://sexualhealthalliance.org.au/
Describe the main purpose and function of your organisation (300 words max) The Australasian Sexual Health Alliance (ASHA) is a group of partner organisations established to improve national and local responses to sexual health issues, via a multidisciplinary support network for the sexual health workforce. It aims to strengthen bonds between specialists, GPs, nurses, researchers and other key contributors to the sexual health sector, through collaboration in sexual health education, training, policy-making and research. ASHA was formed as a committee of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). ASHM provides much of ASHAâ&#x20AC;&#x2122;s infrastructure including the provision of secretariat, technical support, annual conference facilitation, and funding support. The committee of ASHA provides the guidance upon which ASHM acts in relation to policy, educational and resource based support for the sexual health workforce.
Please indicate which disease areas your organisation works with Sexually Transmissible Infections
What are your key programs? Guidelines development
Please list the type of professionals you provide training for: ASHA do not provide training.
Do you provide training for ASHA do not provide training.
78
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Regional Organisations IUSTI
Name of your organisation
Name of the person completing this survey
International Union against Sexually Transmitted
Somesh Gupta
Infections- Asia-Pacific Region
Name of the person representing your Organisation who will be attending the 1st Regional Assembly Somesh Gupta
Please provide your website address www.iusti.org
Describe the main purpose and function of your organisation (300 words max) The International Union against Sexually Transmitted Infections (IUSTI) was founded in 1923 and it is organized on both a global and regional basis. It is the oldest international organisation with the objective of fostering international cooperation in the control of sexually transmitted infections including HIV/AIDS. IUSTI is concerned with the medical, scientific, social and epidemiological aspects of sexually transmitted infections and their control. IUSTI is on the Roster of the United Nations Economic and Social Council. It is an Official Non-Government Organisation in Consultative Status with the World Health Organisation. IUSTI organizes frequent international and regional conferences on sexually transmitted infections and, in collaboration with the International Journal for STD and AIDS, publishes expert clinical guidelines for their management.
Please indicate which disease areas your organisation works with HIV, Sexually Transmissible Infections, Co-infections
What are your key programs? Clinical/technical education, CME, Training, Guidelines development
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Access to testing/diagnosis, HIV, STIs, Co-infections, Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health
What are the areas of need for the professionals you provide training for? (Please enter different answers per professional group. If the need is the same across all areas please only provide one answer. for example: Technical: laboratory, testing, management. Health promotion, advocacy, guideline and policy development. Training: introduction to HIV,HBV,HCV, STIs and advanced training in HIV,HBV,HCV, STIs) Area 1: Training and teaching: Diagnostic, Clinical, Public Health, Treatment Guidelines, for STI
Do you provide training for Members only, Fellows/Trainees, General healthcare professionals
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
79
Regional Organisations Oceania Society for Sexual Health and HIV Medicine (OSSHM)
Name of your organisation
Name of the person completing this survey
Oceania Society for Sexual Health and HIV Medicine
Dr Arvin Chaudhary
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr Arvin Chaudhary
Please provide your website address www.osshhm.org
Describe the main purpose and function of your organisation (300 words max) OSSHHM’s objectives are: •
To help ensure that health care workers who work in the field of STI/HIV and sexual health have increased access to comprehensive STI/HIV and sexual health care training
•
To have increased access to relevant resources to assist with the delivery of evidence-based care.
•
To provide a key network between all health care workers providing STI/HIV and sexual health care in the Pacific.
•
To perform its role of providing ongoing health worker professional
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections, sexual health (erectile dysfunction, men's and women's health)
What are your key programs? Clinical/technical education, CME, Training, Guidelines development
What are the key issues for your country/region? Access to care/treatment, Access to monitoring, Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV, STIs, Co-infections, Tuberculosis
Please list the type of professionals you provide training for: Doctors, Nurses, Allied health
Areas of need for the professionals you provide training for? Area 1: Technical support and research work Area 2: Guidelines and up to date recommendations Area 3: Training
Do you provide training for? Members only, Fellows/Trainees, General healthcare professional Pacific Society for Reproductive Health
80
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Regional Organisations Pacific Society for Reproductive Health
Name of your organisation Pacific Society for Reproductive Health
Name of the person representing your organisation who will be attending the 1st Regional Assembly Dr. Alec Ekeroma
Please provide your website address http://psrh.org.nz/
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
81
Regional Organisations TREAT Asia/amfAR
Name of your organisation
Name of the person completing this survey
TREAT Asia/amfAR
Annette Sohn
Name of the person representing your organisation who will be attending the 1st Regional Assembly Annette Sohn
Please provide your website address http://amfar.org/treatasia.html
Describe the main purpose and function of your organisation (300 words max) TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) is a collaborative network of clinics, hospitals, research institutions, and civil society that is working to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies.
Please indicate which disease areas your organisation works with HIV, Hepatitis B, Hepatitis C, Sexually Transmissible Infections, Tuberculosis, Co-infections
What are your key programs? Clinical/technical education, Research, advocacy/policy
What are the key issues for your country/region? Access to care/treatment, Access to monitoring , Engaging key affected populations, Access to testing/diagnosis, HIV, HBV, HCV, STIs, Co-infections, Tuberculosis, Stigma, discrimination, health-related human rights
Please list the type of professionals you provide training for: Doctors, Nurses, Peer/community workers
What are the areas of need for the professionals you provide training for? Area 1: New treatments for HIV and co-infections Area 2: Engaging key populations with or at risk for HIV Area 3: Working with adolescents with HIV
Do you provide training for Network members, clinicians linked to our network partners, regional and national
82
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Dr. Ly Peng sun and Dr. Samreth Sovannarith
Director and Head of AIDS Care Unit
President Director
Chairman of the board (president) Science and Technology Advisor
President President
National Center for HIV/AIDS, Dermatology and STD
Individual member
AIDS institute
Center for Liver Health, Division of Gastroenterology and Hepatology
AsiaHep
The HIV Medical Association of India (HIVMAI
Indian Society of Gastroenterology
Eijkman Institute
Angsamerah Institution
Indonesia Medical Association (IDI)
The Japanese Society for AIDS Research
Japan Agency for Medical Research and Development (AMED)
Mahosoth Hospital
Malaysian Society for HIV Medicine
Malaysian Academy of Medicine
Myamar Liver Foundation
Oceania Society for Sexual Health and HIV Medicine (OSSHHM) Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP)
PNG Sexual Health Society
AIDS Society of the Philippines (ASP)
Cambodia
Hong Kong
Hong Kong
Hong Kong
Hong Kong
India
India
Indonesia
Indonesia
Indonesia
Japan
Japan
Laos
Malaysia
Malaysia
Myanmar
Pacific
Papua New Guinea
Philippines
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
President
President
Deputy President
President
Head of HIV Care and Treatment
IDI HIV Program Coordinator
Founder and Director
Deputy Director for translation research
Hon Secretary
Chief Medical Officer
Founding chairperson
Dr Graham Neilsen
International consultant in sexual health and development
Australia
Yes Yes
John Millan Dr. Maria Isabel E. Melgar
Yes
Yes
Dr. Khin Pyone Kyi and Dr. Phone Myint Win Arvin Chaudhary
Yes
Yes
No
No
Yes
No
Yes
No
No
Yes
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Sending a representative Yes
Yes
Yes
Yes
Members
No
No
Yes
Attending the assembly
Prof Rosmawati Mohamed
Suresh Kumar
Dr. Prasith Phimmasone
Dr Aikichi Iwamoto
Shuzo Matsushita
Dr. Dyah Agustina Waluyo
Dr. Nurlan Silitonga
Dr Rakesh Kochhar
Dr.N.Kumarasamy
Dr Nancy Leung
Prof Henry Lik Yuen Chan
Professor Zhiwei Chen
KH Wong
Levinia Crooks
CEO
Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine
Australia
Name
Role
Organisation
Country
Regional Network Members and Contacts
83
Yes
Regional Network Members and Contacts
84
1st Assembly of the Regional Network on HIV, Viral Hepatitis and Sexual Health - Strengthening collaboration & capacity in Asia Pacific
Notes
LMB 5057 Darlinghurst NSW 1300 Australia | t +64 2 8204 0700 | f +64 2 9212 2382 | e regionalnetwork@ashm.org.au
85